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Abstract 
 
Background 
Several studies link the consumption of whole-grain products to a lowered 
risk of chronic diseases, such as certain types of cancer, type II diabetes, and 
cardiovascular diseases. Cereal fibre together with the biologically active 
compounds associated with the dietary fibre complex have been proposed to be 
protective. However, the final conclusions of the exact protective mechanisms 
remain unclear, partly due to a lack of a suitable biomarker for the whole-grain 
cereals intake. The mammalian lignan enterolactone (ENL) has previously been 
suggested to function as a possible biomarker for whole-grain intake, but is 
produced in the human gut from lignans in several plant products in the diet. 
Alkylresorcinols (AR) are phenolic lipids abundant in the outer parts of wheat and 
rye grains usually with homologues of C15:0-C25:0 alkyl chains. According to in 
vitro studies they possess several biological activities and have been proposed to 
function as specific biomarkers of whole-grain intake. The total amount of AR and 
the homologue ratios are different in wheat and rye grains. 
 
Aims 
In the present work a quantified method for the analysis of AR in plasma 
was developed. The method was used to determine human and pig plasma AR 
concentrations after the intake of whole-grain wheat and rye products compared 
to low-fibre wheat bread diets to assess the usability of AR as biomarkers of 
whole-grain intake. AR plasma concentrations were compared to serum ENL 
concentrations. AR absorption and elimination kinetics were investigated in a pig 
model. AR occurrence in human erythrocyte membranes and plasma lipoproteins 
were determined, and the distribution of AR in blood was evaluated.  
 
Methods 
Plasma AR were analysed by gas chromatography – mass spectrometry 
(GC-MS) after incubation with water, extraction, and purification with ion 
exchange chromatography (Study I). For the analyses of erythrocyte AR, the cells 
were separated, washed and deproteinised, AR were extracted and the samples 
were purified in a similar manner as with plasma analysis. Lipoproteins were 
isolated by sequential ultracentrifugation. Lipoprotein AR were analysed in a 
similar manner as plasma, but extracted four times for better analyte recovery. 
Serum ENL concentrations were measured by time-resolved fluoroimmunoassay. 
 
In a randomised, crossover dietary intervention (2x8 weeks) with intake of 
whole-grain rye and low-fibre wheat bread, plasma AR and serum ENL 
concentrations from 39 postmenopausal women were measured and compared to 
habitual diet (Study II). AR were analysed in human plasma and erythrocyte 
membranes (n=4) after a one-week intake of whole-grain products compared to a 
one-week intake of low-fibre products. The concentrations were compared to 
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those of the subjects with a two-weeks habitual diet (n=4) (Study III). Plasma, 
erythrocyte, and lipoprotein AR were analysed (n=8 women, 7 men, n=total of 15) 
after constant intake of whole-grain rye or wheat crisp bread in a 1x1 week 
crossover study. Before the study weeks the subjects followed a low-fibre wheat 
bread diet for one week (Study V). AR absorption and elimination kinetics were 
determined in a pig model. Four pigs were constantly fed either whole-grain rye 
bread with rye bran or low-fibre white wheat bread. In part 1 of the study, AR 
appearance in plasma from portal vein and mesenteric artery was followed for 9 h 
on days 5 and 7 of the feeding study. In Part 2, AR appearance was followed for 
16 h after single feeding of rye bread after a 5-day low-fibre diet. The study was 
repeated for each pig (Study IV). 
 
Results 
AR can be quantified in plasma, erythrocytes, and lipoproteins using a GC-
MS method. Fasting plasma AR concentrations (n=39) were significantly (p < 
0.001) higher after an eight-week consumption of whole-grain rye bread (214±7.1 
g/d (mean±SEM), 352±24.7 nmol/l) or after an eight-week habitual Finnish diet 
(88.3±8.7 nmol/l) compared to an eight-week low-fibre bread period (36.6±4.2 
nmol/l). Plasma AR concentrations correlated with the intake of rye bread (r=0.34, 
p < 0.05). After a one-week constant intake of whole-grain rye or wheat crisp 
bread (97.5±0.97 and 95.5±2.1 g/d, respectively, n=15) plasma AR concentrations 
increased significantly (222±24.5 and 107±14.1 nmol/l, respectively) compared to 
the one-week low-fibre bread diets (30.1±10.7 and 25.4±3.0 nmol/l) (p < 0.05), but 
inter-individual variation in the concentrations was high, 55.1-389 nmol/l after 
whole-grain rye intake and 34.4-231 nmol/l after whole-grain wheat intake. No 
correlation to individual bread intake was seen, although mean plasma AR 
concentrations increased significantly with the increasing intake of AR from whole-
grain wheat bread and more with whole-grain rye bread. AR homologue 
C17:0/C21:0 –ratio was significantly different after intake of whole-grain wheat 
and rye compared to low-fibre periods or habitual diet (p < 0.05).  
 
ENL concentrations increased in women (n=39) with the eight-week whole-
grain rye bread intake and in men (n=7) with the one-week whole-grain rye bread 
intake, but not with whole-grain wheat bread. With women (n=8) no increase was 
seen within one week with whole-grain rye or wheat crisp bread intake, although 
AR concentrations did increase. The changes in ENL concentrations were smaller 
and more variable than in AR when related to the intake of whole-grain products.  
 
There was no difference in AR concentrations measured from pig portal 
vein and mesenteric artery after the intake of whole-grain rye bread. The 
maximum plasma AR concentration was seen at 3-4 h with single feeding. The 
absorption half-life was 1.20 h and apparent elimination half-life 3.93 h. 
 
We determined AR in erythrocyte membranes, and their concentrations 
increased significantly with a one-week intake of whole-grain rye or wheat bread 
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(315±31.2 and 210±17.3 nmol/l of packed cells, respectively) compared to low-
fibre bread diet (n=15). In another study (n=4) erythrocyte AR concentrations 
increased 231±63.7 nmol/l of packed cells with a one-week whole-grain bread 
intake compared to a one-week low-fibre bread diet.  
AR are incorporated into VLDL, 46±2.1% of the total AR(mean±SEM, n = 
15), LDL, with 20±1.3%, and HDL, with 33±1.5%, and their concentrations 
systematically increase with the intake of whole-grain wheat and rye bread 
compared to low-fibre wheat bread. 
 
Conclusions 
Plasma AR seem to be absorbed via the lymphatic system from the small 
intestine, like many other lipophilic compounds. Their apparent elimination half-life 
is relatively short and is similar to that of tocopherols, which have a similar 
chemical structure. AR are incorporated into erythrocyte membranes. It is possible 
that erythrocyte AR concentrations reflect a longer term intake of AR. Plasma AR 
concentrations increased significantly after a one- to eight-week intake of whole-
grain wheat and rye bread. The concentrations were also higher after habitual 
Finnish diet compared to diet with low-fibre bread. Inter-individual variation after a 
one-week intake of the same amount of bread was high, but the mean plasma AR 
concentrations increased with increasing AR intake. In one study a correlation 
between plasma AR and bread intake was seen. AR are incorporated into plasma 
lipoproteins, and VLDL and HDL were the main AR carriers in human plasma. 
 
Based on these studies, plasma AR could function as biomarkers of dietary 
whole-grain products. AR are exclusively found in whole-grains and are more 
suitable as specific biomarkers of whole-grain intake than previously suggested 
mammalian lignan ENL. Plasma AR C17:0/C21:0 –ratio could distinguish whether 
whole-grain products in the diet are mainly wheat or rye. Further and prolonged 
studies are needed to confirm these data and the analysis of AR in large 
epidemiological studies could eventually demonstrate their functionality as 
biological markers.  
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Introduction 
 
In the face of an increase in the incidences of diet associated diseases, 
more attention has been paid to improve human nutrition. One of the recent 
recommendations is to include whole-grain products in the daily diet. 
Consumption of whole-grain cereals has been linked to a reduced risk of several 
chronic diseases, such as type II diabetes, certain cancers, and cardiovascular 
diseases (CVD) (Slavin et al. 2001, Truswell 2002). Cereal fibre and several 
compounds associated with it, as well as their synergistic effects, have been 
suggested to be protective (Lapointe et al. 2006, Slavin 2003, Slavin et al. 1999, 
Steinberg 1997). However, an apparent disease preventive role of whole-grains 
and the exact protective mechanisms have remained uncertain. A reliable 
biomarker for whole-grain intake is needed to verify the intake and to clarify the 
relation of the intake of whole-grains to disease prevention (Edge et al. 2005). 
 
Alkylresorcinols (AR) are phenolic lipids abundant in the outer parts of the 
kernels of whole-grain wheat and rye, which are two of the main cereals 
consumed by humans. AR have been shown to be biologically active and possess 
membrane stabilizing and antioxidative properties when incorporated into 
biological membranes (Kozubek and Tyman 1999, Ross et al. 2004b). AR, being 
specific for whole-grain wheat and rye in the human diet, have been suggested to 
function as dietary biomarkers of whole-grain intake (Ross et al. 2004b, Ross et 
al. 2001b). Previously, concentrations and occurrence of AR in vivo were 
unknown, and therefore verifying the usability of AR as biomarkers in humans has 
been difficult. 
 
In the present study, a new method for the analysis of AR in plasma was 
developed. The method was used to measure AR concentrations in human and 
pig plasma after the intake of whole-grain wheat and rye bread to determine AR 
usability as biomarkers of whole-grain intake. With modifications, the method was 
used to measure AR in human erythrocytes and plasma lipoproteins to assess AR 
incorporation into the membranes and their distribution in blood. 
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1 Review of the literature 
 
1.1 Epidemiological studies of the role of whole-grain products 
on human health and possible protective mechanisms 
 
Recently, increasing attention has been paid to human nutrition and its role 
in health promotion and prevention of chronic diseases (Marquart et al. 2003, 
Slavin 2004). Several epidemiological studies have linked the intake of whole-
grains to a reduced risk of certain chronic diseases, such as type II diabetes, 
cardiovascular diseases (CVD), obesity, and certain types of cancer (Hallmans et 
al. 2003, Slavin et al. 2001, Truswell 2002). The exact protective mechanisms of 
whole-grains have remained unclear, although several biologically active 
compounds, such as vitamin E, folate, and phenolic compounds have been 
investigated (Slavin 2003, Slavin et al. 1999). Grain kernels are structurally 
divided into three main fractions: bran and aleurone layer, endosperm, and germ. 
They vary largely in chemical and structural composition. The germ includes 
lipids, proteins, minerals, and most of the vitamins, including vitamin E, while 
endosperm contains mainly carbohydrates and some proteins (Slavin 2004). Most 
of the biologically active compounds together with structural polymers in the fibre 
complex exist in the bran fraction of the grains (Trowell 1976). Grain processing 
can increase the amount of bioactive compounds or their bioavailability by 
releasing them from the matrix. On the other hand, in highly refined products most 
of the bioactive compounds are removed together with the bran (Slavin 2004). 
 
Indigestible carbohydrates in whole-grains, most importantly insoluble fibre, 
increase faecal weight and decrease intestinal transit time (Bruce et al. 2000). 
The intake of dietary cereal fibre has been linked to reduced body weight by 
several mechanisms, such as the intake of insoluble fibre, or fermentability of 
fibre, and soluble fibre, or the viscosity of fibre, which both can affect energy 
metabolism with hormonal, colonic, and intrinsic effects (Slavin 2005). Fermented 
carbohydrates, and their metabolites, short-chain fatty acids, can reduce serum 
cholesterol concentrations and decrease the risk for colon cancer (Slavin 2004). A 
reduced risk for cancer has been explained also by other mechanisms, such as 
decreased faecal transit time, and dilution and esterification of bile acids (Korpela 
et al. 1992, Zhang et al. 1993). The reduced cancer risk has also been suggested 
to be linked to the intake of certain minerals, vitamins, such as vitamin E, and 
bioactive compounds, such as mammalian lignan enterolactone (ENL) (Slavin 
2004 and references therein). ENL has been proposed to protect against certain 
diseases, such as breast, prostate, and colon cancers, and CVD (Adlercreutz 
2002, Adlercreutz and Mazur 1997, Thompson 1998). ENL has been linked to a 
reduced risk of these diseases (Ingram et al. 1997, Pietinen et al. 2001, 
Vanharanta et al. 2003), although opposite data has been presented for breast 
(Kilkkinen et al. 2004) and prostate cancer (Kilkkinen et al. 2003, Stattin et al. 
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2002), and no final conclusions about its role in disease prevention has been 
made (Boccardo et al. 2006, Ganry 2005, Kilkkinen et al. 2006).  
 
Whole-grains slow the digestion, tend to have a low glycaemic index, they 
can improve insulin sensitivity (Pereira et al. 2002), affect glucose and insulin 
metabolism, and thereafter reduce a risk of type II diabetes mellitus (Montonen et 
al. 2003, Salmeron et al. 1997, Slavin 2004). Therefore, whole-grains can possibly 
also reduce the risk of certain cancers, since high serum insulin has been linked 
to colon and breast cancer (Slavin 2004 and references therein). McIntosh et. al 
(2003) showed that rye fibre-based food, compared to wheat fibre-based food, is 
more effective in improving bowel health biomarkers, and it reduced faecal β-
glucuronidase, postprandial insulin and plasma glucose concentrations, and 
increased faecal butyrate and faecal output (McIntosh et al. 2003). Jensen et al. 
recently correlated lower homocystein concentrations, lower insulin, C-peptide, 
and leptin levels to whole-grain intake (Jensen et al. 2006). The intake of whole-
grains has been linked to reduced all-cause mortality. In the Iowa Women’s 
Health Study, the total mortality of post-menopausal women was inversely 
associated with whole-grain intake but positively associated with refined grain 
intake (Jacobs et al. 1999, Jacobs et al. 2000). In the Norwegian County Study, 
the total mortality of women and men was inverse and graded across whole-grain 
consumption. 
 
Pietinen et al. (1996) showed an inverse association between cereal fibre 
and CHD mortality that remained significant after adjustment to other dietary 
factors. They speculated that postprandial lipid response, glucose and insulin 
metabolism, or haemostatic factors may be the factors explaining the findings  
(Pietinen et al. 1996). Liu et al. suggested that the lower risk of CHD events 
associated with high intake of whole-grains could be explained by the intake of 
dietary cereal fibre, vitamin B6, folate, and vitamin E (Liu et al. 1999). The intake 
of cereal fibre has been linked to a reduced risk of CHD (Liu et al. 1999, Wolk et 
al. 1999) and myocardial infarction (Rimm et al. 1996). Interestingly, in some 
studies soluble fibre has shown no effect on CHD risk (Rimm et al. 1996). Total 
mortality and cardiovascular mortality have been inversely associated with whole-
grain breakfast cereals compared to refined breakfast cereals (Liu et al. 2003). 
Jensen et al. (2004) found a link between the intake of whole-grains, and 
specifically bran, and a reduced risk of CHD (Jensen et al. 2004). They stated, 
however, that other factors, such as overall healthier diet and lifestyle, and total 
fibre from the diet can affect the results. A 23% risk reduction was seen in 
coronary heart disease (CHD) and cardiovascular deaths, and a 21% risk 
reduction in cancer death rate between the highest and the lowest whole-grain 
bread intake score   (Jacobs et al. 2001). The intake of whole-grain cereals has 
also been linked to lower total cholesterol and LDL levels (Bruce et al. 2000, 
Jensen et al. 2006). Truswell (2002) reviewed several studies concerning whole-
grains and CHD risk, and concluded that there was no clear association between 
total cereal consumption and CHD. However, Truswell reported that five separate 
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epidemiological cohort studies showed an inverse association of cereal fibre or 
whole-grains and CHD, and that the results can partly be explained by the 
cholesterol lowering effect of fibre, although several other mechanisms may be 
involved (Truswell 2002). 
 
In addition to fibre, certain compounds, such as vitamin E (tocopherols and 
tocotrienols), plant sterols, fermentable carbohydrates and oligosaccharides, and 
their metabolic end-products, have been suggested to play a role in disease 
prevention (Slavin et al. 1999). For example, whole-grain antioxidants and many 
phenolic compounds have been shown to affect the risk factors of CHD (Slavin 
2004), and it is thought that the synergistic effect of different compounds in the 
fibre complex of whole-grains is the key factor in disease prevention (Slavin 2003, 
Slavin 2004). 
 
Antioxidants protect tissues against free radicals that can affect DNA, 
lipids, and proteins by initiating processes leading to several chronic diseases. 
Total antioxidant activity in whole-grains is relatively high, even higher than in 
most fruits and vegetables (Miller et al. 2000). However, difficulties in measuring 
the antioxidant capacity in foods have lead to contradictory results. There has also 
been speculation on how important the total antioxidant capacity of whole-grain 
products is for human health (Seal 2006), since most of the trials are performed in 
vitro. Only recently more attention has been paid to the bioavailability of the 
studied compounds and to the testing methods of the antioxidant capacity of 
whole-grain cereals (Adom and Liu 2005, Liyana-Pathirana and Shahidi 2006). 
 
Vitamin E is regarded as the most important lipid-soluble antioxidant 
(Bjørneboe et al. 1990, Burton et al. 1983, Chow 1985). It can protect 
polyunsaturated fatty acids from oxidation and retain selenium in a reduced state 
and act as an intracellular antioxidant (Slavin 2004). Several antioxidants, such as 
soluble phenolic acids, flavonoids, tocopherols, and insoluble matrix-bound 
antioxidants, as well as compounds produced during food processing, can have 
local effects on the cells in the intestinal wall and systemic effects after absorption 
(Slavin 2003, Slavin 2004). However, total antioxidant capacity might not tell 
whether the tested compounds are actually absorbed in human subjects and 
whether they have biological effects in vivo. 
 
LDL in its oxidised form is found in atherosclerotic plaques and plays an 
important role in atherosclerosis. In the arterial wall LDL can undergo oxidative 
modification and attract monocytes into the arterial lesion leading to the formation 
of macrophages and foam cells and eventually fully developed ateromas (Berliner 
et al. 1995, Steinberg 1997). LDL oxidation and thereafter cellular events involved 
in atherosclerosis development might be affected by dietary components, such as 
vitamin E (Kaul et al. 2001, Lapointe et al. 2006, Princen et al. 1995). Several 
other compounds, such as ascorbic acid, β-carotene, fatty acids, polyphenol 
compounds, such as flavonoids, and certain foods in general, such as fruits, olive 
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oil, tea, and red wine, and even whole diets, Mediterranean diet in particular, have 
been investigated in relation to preventing LDL oxidation (Lapointe et al. 2006). 
Most data regarding LDL susceptibility to oxidation is based on in vitro studies, 
and relating the results to human subjects is difficult since circumstances in vivo 
are remarkably different.  
 
There are only a few published studies of the effects of whole-grain cereals 
on LDL oxidation. In the study by Jenkins et al., the intake of wheat bran had no 
clear effect on LDL concentration or oxidation during a three months follow-up. 
(Jenkins et al. 2002).  In another study, rye bran enriched bread intake for six 
weeks did not affect LDL oxidation lag-time compared to habitual diet or low-fibre 
wheat diet (Harder et al. 2004). However, ferulic acid, and other 
hydroxycinnamates extracted from rye have in other studies shown inhibition of 
LDL oxidation in vitro (Andreasen et al. 2001). So far, no conclusion regarding the 
diet and LDL oxidation has been made, but a synergistic effect of certain foods or 
compounds has been suggested. As with CVD and CHD, more controlled and 
dose-dependent studies with specific compounds and foods are needed to 
determine whether certain diets are cardio-protective (Lapointe et al. 2006). 
 
1.2 Biomarkers of dietary intake 
 
Most of the data in epidemiological studies of the effects of whole-grain 
intake is based on food frequency questionnaires and food diaries, which are 
dependent on memory and accurate and unambiguous reporting, and are prone 
to subjects’ unconscious altering of dietary habits during reporting (Kaaks et al. 
1997, Wild et al. 2001). Self-reporting has been stated to flatten the association of 
dietary factors with disease end-points and cause within-person errors (Jacobs et 
al. 2001). In epidemiological studies other measures of consumption, such as 
food consumption data or food supply data are used, but often no data of 
individual intake is available (Kantor et al. 2001). Food composition tables provide 
information of average food ingredients, but can cause errors in epidemiological 
studies. Difficulties in defining whole-grain foods and serving sizes can disturb 
data interpretation in epidemiological studies regarding the role of whole-grains in 
the diet (Kantor et al. 2001, Lang and Jebb 2003, Liu et al. 1999). A reliable 
biomarker of whole-grain intake would provide information on cereal consumption, 
and a biomarker that could distinguish between the intake of whole-grain cereals 
and other products considered healthy, such as fruits and vegetables, could 
provide conclusive data about their possible protective roles in the diet. According 
to Scientists from the Whole Grains and Health Summit in 2005, the long-term 
effects of whole-grain intake and risk of chronic diseases, as well as the 
compounds responsible for the health effects should be investigated, and the 
bioavailability of the bioactive compounds should be determined. Therefore, a 
biomarker of the intake of whole-grains, specific grains, or grain components is 
needed. (Edge et al. 2005).  
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A good biomarker should be highly sensitive and specific, minimally 
invasive, inexpensive, and its analysis method should be validated and 
standardised (Crews et al. 2001, Weber 2001). It should provide more accurate 
and objective data than obtained by traditional methods (Kaaks et al. 1997). 
Individual absorption, metabolism, excretion, and interactions in human body can 
affect the reliability of a biomarker. The choice of the matrix where it is analysed 
in, e.g. plasma, cell membranes, or tissues, as well as metabolic end-products of 
the measured compound, are important when determining the link between 
exposure and a biomarker. (Crews et al. 2001, Kaaks et al. 1997). Measurement 
reproducibility is affected by a compound’s metabolic turn-over rate and the 
stability of dietary intake, as well as its redistribution and storage in the body 
(Kaaks et al. 1997). There is a lack of knowledge of absorption, distribution, and 
storage of many non-nutrients in the diet. Dose-dependent studies are scarce, 
and most of the studies of non-nutrients as biomarkers have focused on the intake 
of whole food, where complexity and other food components affecting absorption 
and distribution can affect the results (Crews et al. 2001). Absorption of lipophilic 
compounds like vitamin E, for example, is enhanced by the simultaneous intake of 
fat (Kaaks et al. 1997). If the biomarker is a metabolic end-product, its 
concentration is a combination of intake, absorption, and metabolism, and might 
not correlate solely to intake. (Wild et al. 2001). Short-term variation and intra-
individual variation’s effect on distribution, retention, and interactions within the 
body should be determined (Grandjean 1995). 
 
According to Kaaks et al. (1997), biomarkers can be divided into those that 
provide an absolute quantitative and time-related measure of dietary intake, which 
requires knowledge on pharmacokinetics and metabolic balance between the 
intake and excretion of the compound, and into those that measure the 
concentration of a given factor in biological fluids or tissues, and provide a 
correlation to a dietary factor, but for which there is no time dimension, and 
therefore only provide a correlation to dietary intake level. Most of the biomarkers 
fall into the latter category and only give information whether individuals can be 
classified based on high or low dietary intake. In addition to a biomarker’s ability to 
identify certain dietary factors related to incidence of diseases, the biomarker itself 
could be biologically active. (Kaaks et al. 1997). This, however, is not necessary. 
 
The mammalian lignan enterolactone (ENL) has been studied as a 
potential biomarker for whole-grain intake  (Stumpf 2004). ENL, and another 
lignan metabolite enterodiol, are formed by intestinal microflora from plant lignans 
present widely in nature (Borriello et al. 1985, Setchell et al. 1981, Setchell et al. 
1980). Enterodiol is further converted to ENL. The main sources of plant lignans in 
human diet are berries, fruit, vegetables, oily seeds, especially flaxseed and 
sesame seed, wine, and whole-grains (Mazur and Adlercreutz 1998, Milder et al. 
2005, Peñalvo et al. 2005a). Whole-grains, rye in particular, have been known to 
contain plant lignans matairesinol and secoisolariciresinol (Nilsson et al. 1997). 
Recently, other mammalian lignan precursors have been identified in rye 
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(Heinonen et al. 2001), and in other plants (Peñalvo et al. 2005b, Saarinen et al. 
2000). The intake of whole-grain cereals, spefically rye, has been linked to 
increased ENL concentrations, but no direct correlation to intake has been shown 
(Jacobs et al. 2002, Juntunen et al. 2000, Kilkkinen et al. 2001, Kilkkinen et al. 
2002, Vanharanta et al. 2002). It is thought that since enterolactone is produced 
from several sources in the diet, it, together with enterodiol, would reflect a 
healthy diet and the intake of lignans or individual gut microflora activity instead of 
the intake of a certain food (Horner et al. 2002, Johnsen et al. 2004, Kilkkinen et 
al. 2002, Stumpf 2004, Stumpf et al. 2000a). 
 
1.3 Cereal alkylresorcinols 
 
1.3.1 Occurrence of alkylresorcinols in foods 
Cereal 5-n-alkylresorcinols (AR) are lipophilic 1,3-dihydroxybenzene 
derivatives that differ mainly with their odd-numbered hydrocarbon chains 
attached to position 5 of the benzene ring. Their structure resembles that of 
tocopherols that have a chromanol ring with a phenolic group and a hydrocarbon 
phytyl chain with 16 carbons (Figure 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Chemical structures of alkylresorcinol, tocopherol, and tocotrienol, and list 
of tocopherol and tocotrienol side chains. The dashed lines in alkylresorcinol structure 
represent different alkylresorcinol homologue lengths (C15:0-C25:0). 
Compound R1 R2 R3 
α-tocopherol/α-tocotrienol CH3 CH3 CH3 
β-tocopherol/β-tocotrienol CH3 H CH3 
γ-tocopherol/γ-tocotrienol H CH3 CH3 
δ-tocopherol/δ-tocotrienol H H CH3 
O
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Tocotrienol 
O
R1
HO
R2
R3
Alkylresorcinol 
HO
OH
CH3
 18 
Due to their structure, AR are lipophilic, and their log10 octanol-water 
partition coefficients vary from 8.5 to 13.4, depending on the chain length. Log10 
octanol-water partition coefficient is, for example, above 8 and mostly around 12 
for fat-soluble vitamins (A, D, E, and K), and 1.4 and -4.0 for water-soluble ferulic 
acid and L-ascorbic acid, respectively (Eastwood 1999). AR are named in a 
similar way as fatty acids (Table 1). As an example, AR with a hydrocarbon chain 
with 17 carbon atoms is named as AR C17:0.  
 
 
Table 1. Nomenclature of alkylresorcinols, their molecular weights, and their 
homologue percentages in different cereals *(Ross et al. 2003c).  
 
 
In nature, the highest amounts of AR are found in the Triticae subfamily of 
the meadowgrass (Poaceae) family in rye, wheat, and triticale, and in small 
amounts in barley (Kozubek and Tyman 1999, Ross et al. 2003c), with 
homologues varying from C15:0 to C25:0. AR are not found in other subfamilies of 
meadowgrass, such as oats, rice, corn, millet, or sorghum (Mattila et al. 2005, 
Ross et al. 2003c). AR are located in the bran fraction, in pericarp and testa of the 
grain, and in aleurone layer, but only in minute amounts in the endosperm. Their 
relative homologue percentages are similar in all grain parts, but differ between 
the species (Table 1) (Ross et al. 2001a). In addition to cereals, certain AR 
homologues are found in some bacteria, fungi, and in some higher plants, but not 
in the edible parts of these species (Bandyopadhyay et al. 1985, Kozubek and 
Homologue%* 
Alkylresorcinol name 
Empirical 
formula 
Abbreviation 
Molecular 
weight 
(g/mol) Rye Wheat Barley 
5-n-pentadecylresorcinol, 
5-pentadecyl-1,3-
benzenediol 
(cardol, adipostatin A) 
C15H31 C15:0 320 1-2 - - 
5-n-heptadecylresorcinol, 
5-heptadecyl-1,3-
benzenediol 
C17H35 C17:0 348 23-25 4-5 3-10 
5-n-nonadecylresorcinol, 
5-nonadecyl-1,3-
benzenediol 
C19H39 C19:0 376 31-32 29-35 11-13 
5-n-heneicosylresorcinol, 
5-heneicosyl-1,3-
benzenediol 
C21H43 C21:0 404 22-25 46-51 24-27 
5-n-tricosylresorcinol, 
5-tricosyl-1,3- 
benzenediol 
C23H47 C23:0 432 10-11 0-12 16-18 
5-n-pentacosylresorcinol, 
5-pentacosyl-1,3-
benzenediol 
C25H51 C23:0 460 8-10 3-4 35-44 
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Tyman 1999, Ross et al. 2003c). AR are found in certain soil bacterial walls, e.g. 
in Azotobacter chroococcum and in Pseudomonas species, where they can affect 
membrane metabolism, have antioxidative properties, and provide biochemical 
protection for the bacteria (Bitkov et al. 1992, Kozubek et al. 1996). In plants AR 
might provide protection against pathogens, such as fungi, during seedling 
development (Deszcz and A. 2000, García et al. 1997, Miché et al. 2003). 
 
AR homologue C17:0/C21:0 –ratio was about 0.1 in wheat based products 
and about 1.0 in rye based products, and it has been suggested to indicate the 
type of cereals in foods (Chen et al. 2004, Ross et al. 2004b). Barley contains 
exceptionally high amounts of C25:0 (Chen et al. 2004, Ross et al. 2003c, 
Zarnowski et al. 2002). The main AR homologues in wheat and rye are C17:0-
C25:0 with saturated hydrocarbon chains, but low amounts of homologues with 
unsaturated hydrocarbon chains or with hydroxyl or keto-groups in the chains are 
present in <10% in wheat, barley, and triticale, and in ~20% in rye (Kozubek and 
Tyman 1995, Ross et al. 2003c, Seitz 1992). Structures with two resorcinol 
groups exist in minor amounts in grains (Suzuki et al. 1999).  
 
Chen et al. (2004) reported AR concentrations of 227-639 µg/g DM for 
whole-grain wheat grains and on average 8 µg/g DM for barley grains  (Chen et 
al. 2004). Ross  et al. (2003) measured AR concentrations of 489-618 µg/g DM for 
wheat grains, 720-761 µg/g DM for rye grains, 439-647 µg/g DM for triticale 
grains, and 42-51 µg/g DM for barley grains. Zarnowski et. al (2002) stated that in 
barley AR exist in concentrations of 41-210 µg/g DM (Zarnowski et al. 2002). 
Wheat and rye bran have high amounts of AR, 2211-3225 µg/g DM and 2758-
4108 µg/g DM respectively (Chen et al. 2004, Mattila et al. 2005). In earlier 
studies, extreme AR concentrations up to 5000 µg/g DM for rye grains, 900 µg/g 
DM for wheat grains, and 150 µg/g DM for barley grains were reported 
(Gasiorowski et al. 1996). No AR were detected in white wheat flour or bread 
(Mattila et al. 2005, Ross et al. 2003c). 
 
AR concentrations in wheat and rye vary considerably depending on the 
cultivar and location (Chen et al. 2004, Ross et al. 2003c). For example variation 
of 200-1480 µg/g DM has been reported for several cultivars of Triticum (wheat), 
and concentrations of one cultivar in a single field had a range of over 500 µg/g 
(Ross et al. 2003c). Variation of different analysis methods naturally affects the 
results from different studies. In wheat-based bran or whole-grain products AR 
concentrations have been measured to vary between 142-1784 µg/g DM 
(wholemeal wheat bread-wheat bran based products) (Ross et al. 2003c), and 
whole-grain wheat soft bread contained 202-353 µg AR /g DM (Chen et al. 2004). 
Rye crisp bread contained 490-804 µg AR/g DM (Chen et al. 2004), but AR values 
up to 1007 µg/g DM have been reported (Ross et al. 2003c). Soft whole-grain rye 
bread was reported to contain AR 197-686 µg/g DM (Chen et al. 2004). AR, as 
well as several other bioactive compounds in the bran, seem to remain intact 
during food processing (Liukkonen et al. 2003, Ross et al. 2003c). 
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One average serving of wheat-bran product contains at most ~70 mg AR 
and one serving (40 g) of whole-grain wheat bread about 10 mg AR (Ross et al. 
2003c). Extreme consumers of whole-grains in the United Kingdom were 
suggested to receive up to ~200 mg AR/day (Ross et al. 2003b). Average daily 
intake of AR was estimated to be 11.8  mg/d in the and 22.9 mg/d in Sweden 
based on food consumption data and 11.9 (the United Kingdom), 17.5 (Sweden), 
18.5 (Norway), 39.8 (Finland), and 37.1 (Denmark) mg/d based on food supply 
data (Ross et al. 2005). 
 
AR concentrations in vivo have been unknown and consequently the role of 
AR in biological systems has been unclear. AR, which mainly exist in whole-grain 
wheat and rye products in human diet, have been suggested to function as 
specific biomarkers for whole-grain wheat and rye intake (Ross et al. 2004b). 
They could provide valuable information on the reliability of whole-grain intake 
data for epidemiological studies regarding the link between the intake of whole-
grain products and the occurrence of certain chronic diseases.  
 
1.3.2 Biological effects in vitro 
Antioxidative properties 
AR seem to be rather weak antioxidants per se, as pure compounds in 
vitro. Kamal-Eldin et al. (2001) examined AR antioxidant activity by radical 
inhibition and inhibition of auto-oxidation of sunflower oil triacylglycerols, in 
comparison to α-tocopherol. They saw no antioxidant activity for AR C15:0 
regarding radical scavenging and hydrogen donation power. They explained the 
lack of antioxidant activity by meta-positioned hydroxyl groups, instead of ortho- or 
para-positioning that would lead to enhanced antioxidative properties, at least in 
vitro (Kamal-Eldin et al. 2001, Zhang 1999). They also remarked that the rather 
high redox potentials of AR might not be sufficient to compete with the scavenging 
of oxidised radicals. They criticised the previous results with positive antioxidative 
effects of AR (Kozubek and Nienartowich 1995, Winata and Lorenz 1996), and 
pointed out possible 4-methyl impurity in the tested AR solution and rather high 
concentrations of the tested AR compounds. AR seemed to be poor antioxidants 
compared to vitamin E (Kamal-Eldin et al. 2001). AR have shown a decrease in 
peroxidation products when incorporated into biological membranes (Kozubek 
and Nienartowich 1995). AR could influence other, more potent membrane-bound 
antioxidants, which could explain the stated increased antioxidant activity that 
seemed to be related to AR chain length in some studies. AR with longer chain 
lengths have appeared to be more potent antioxidants. AR metabolites might also 
play a role in antioxidative processes. (Hladyszowski et al. 1998, Kozubek and 
Nienartowich 1995, Kozubek and Tyman 1999, Ross et al. 2004b).  
Parikka et al. (2005) conducted further in vitro studies on AR antioxidant 
activity, and deduced that AR had no direct antioxidative effect, tested by ferric 
reduction ability of plasma (0-1000 µM) or with 2,2-diphenyl-1-picrylhydrazyl 
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radical assay (0-15 µM) compared to hydrophilic ferulic acid. They also examined 
LDL oxidation by monitoring copper-induced formation of conjugated dienes after 
incubating LDL with AR C15:0 and C17:0 (0, 2.5, and 25 µM). They saw a 65-min 
increase in lag-time with C15:0 (25 µM). Similar effect, but to a lesser extent, was 
seen with C17:0. They concluded that AR antioxidant activity might be based on 
their ability to interact with biological membranes. (Parikka et al. 2006). 
 
Alkylresorcinols in membranes 
AR are lipophilic and are able to form liposomal membranes themselves 
and incorporate into biological membranes in vitro (Kozubek 1987a). They can 
affect the liposome size, increase membrane permeability, and enhance the 
bilayer rigidity and stability (Gubernator et al. 1999, Kozubek 1987a, Kozubek and 
Demel 1980). When incorporated into erythrocyte membranes in vitro, AR caused 
haemolysis of erythrocytes at extracellular concentrations of 10-15 µM. 
Haemolytic efficacy was dependant on the degree of saturation and chain length,  
monounsaturated and shorter chain homologues being more effective (Kozubek 
1987b, Kozubek and Demel 1980, Kozubek and Tyman 1999). They can also 
affect membrane mobility and bind, mainly with hydrogen bonds, to adjacent 
cholesterol and phospholipids in the membranes (Kozubek et al. 1988), and to 
proteins, and interact with several membrane-bound enzymes (Kozubek 1995). 
AR, depending on the chain length, are able to inhibit acetylcholinesterase at 
concentrations of 18-90 µM, and increase the activity of Ca2+ -dependent ATPase 
with concentrations up to 50 µM. The effects were explained by direct interactions 
with the enzymes and by indirect membrane-altering effects. (Kozubek et al. 
1992). AR are able to entrap aqueous solutions into the membranes (Przeworska 
et al. 2001). 
 
Other biological effects 
AR may possess antimutagenic and anticarcinogenic activities 
(Gasiorowski et al. 1996). AR, as other compounds with a resorcinol moiety, can 
inhibit cyclo-oxygenase-2 (COX-2) promoter activity, and thereafter might provide 
protection in colon carcinogenesis (Mutoh et al. 2000), to which increased COX-2 
activity has been linked (Wu et al. 2003). According to Parikka et al. (2005), C15:0 
and C17:0 out of the tested C15:0-C23:0 were the most effective at 100 µM and 
24 h incubation in showing an antigenotoxic effect on hydrogen peroxide-induced 
DNA damage in HT29 human colon cancer cells. An increased cellular capacity 
against oxidative damage caused by AR was suggested. Authors pointed out that 
the AR concentrations were several times higher than those usually found in 
plasma, but speculated that high enough tissue concentrations could be reached 
to achieve these effects in vivo. (Parikka et al. 2006). Previously anticarcinogenic 
properties for AR with various chain lengths and tested with several cell lines, 
have been described, as reviewed by Ross et. al (2004) and Kozubek and Tyman 
(1999). AR up to concentrations 12.5 µg/ml (~33 µM), compared to anthocyanins 
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up to concentrations 25 µg/ml (~56 µM) were more potent in reducing the rate and 
frequency of induced mutations in cultured lymphocytes, while anthocyanins were 
more effective in inhibiting free radical generation in human granulocytes in vitro 
(Gasiorowski et al. 2000a). AR together with anthocyanins exhibited 
immunomodulatory effects in lymphocyte cultures (Gasiorowski et al. 2000b). 
Certain AR are able to cause copper-dependent DNA cleavage and inhibit DNA 
polymerase β (Lytollis et al. 1995, Starck et al. 2000). 
 
AR have shown antimicrobial properties against gram-positive bacteria and 
certain fungi and filarial parasites (Himejima and Kubo 1991, Kanda et al. 1975, 
Suresh and Kaleysa 1990). AR seem also to inhibit glycerol-3-phosphate 
dehydrogenase and prevent triacylglycerol accumulation in adipocytes (3T3-L1 
cells), and they showed a 50% reduction of adipocyte triacylglycerols with 
concentrations of 10.7-5.0 µM for C15:0-C21:0 (Rejman and Kozubek 2004). AR 
have been shown to increase platelet thromboxane biosynthesis at concentrations 
of 0.02-2 µM, and the effect was suggested to be due to their haemolytic 
properties on the platelets or their free radical scavenging properties (Hengtrakul 
et al. 1991). 
 
1.3.3 Animal and human studies 
Absorption and elimination 
Average ileal digestibility of AR from rye bran-enriched bread in human 
subjects was ~58% and seemed to be higher for shorter chain homologues, ~59% 
for C17:0-C21:0 and ~47% for C23:0-C25:0. Decreased uptake was suggested 
with higher AR intake (Ross et al. 2003a). With pigs the diet affected AR ileal 
digestibility, and recoveries, i.e. the amount not absorbed for ileal digesta were 
37% after whole-grain and 40% after aleurone, and significantly lower, 21% (p < 
0.01), after pericarp-testa based diet. These diets contained different amounts of 
AR. Pericarp-testa diet provided the lowest and aleurone diet the highest amounts 
of AR. The dose and dietary source of AR, as well as AR metabolism by intestinal 
microflora were suggested to affect the absorption. (Ross et al. 2003b). 
 
AR distribution was studied with rats that were fed a single dose (4.6 
mg/kg) of [4-14C]-5-n-heneicosylresorcinol (14C21:0). Most of the radioactivity was 
found in faeces (61%) and urine (31%), with peak amounts at 24h. Hydrolysis of 
the urine samples resulted in higher recovery suggesting conjugation of the 
compounds or their metabolites. In faeces, 14C21:0 was found mostly unchanged 
and hydrolysis did not improve the recovery. In another experiment with rats with 
14C21:0, almost no radioactivity could be detected after 60h in blood, while peak 
amounts were seen at 7-12 h. (Ross et al. 2003b). AR have been detected also in 
rat perirenal adipose tissues with concentrations of ~2-4 µg/g of fresh tissue 
(Ross et al. 2004a). 
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 Human urine collected after wheat bran diet contained minute amounts of 
intact AR (mainly AR 17:0) in conjugated forms. It was suggested that AR are 
metabolised by ω-oxidation, with further shortening of the alkyl chain by β-
oxidation, and conjugated with glucuronide and/or sulphate (Ross et al. 2004b). 
The end metabolites in urine were determined to be 3,5-dihydroxybenzoic acid 
and 3-(3,5-dihydroxyphenyl)-1-propanoic acid (Ross et al. 2004d). No 
quantisation of the compounds was reported. 
 
Suggested metabolic interactions of alkylresorcinols 
Rats fed a diet with high amounts of AR (1, 2, or 4 g/kg diet or 100-450 
mg/kg body weight/day) had elevated γ-tocopherol concentrations in liver and 
lungs (p < 0.01), while plasma of γ- or α-tocopherol did not change (Ross et al. 
2004a). The authors presented a hypothesis according to which AR inhibit 
tocopherol-ω-hydroxylase pathway, where γ-tocopherol is the major substrate and 
α-tocopherol a poor substrate (Parker et al. 2004), and thereafter inhibit the 
elimination of γ-tocopherol. AR also showed inhibition of synthesis of γ-tocopherol 
water-soluble hydroxychroman metabolites in Hep G3 cell cultures. The sesame 
seed lignan, sesamin, blocks the cytochrome P450 enzyme, tocopherol-ω-
hydroxylase, and therefore strongly inhibits tocopherol ω-hydroxylation, a key step 
in tocopherol metabolism in hepatocytes. This was used as a positive control. The 
effects of AR compared to sesamin were weaker, and the authors concluded that 
AR, instead of direct blockage, might competitively inhibit tocopherol metabolism. 
Shorter chain AR showed a more pronounced effect and they might be more 
extensively metabolized by tocopherol-ω-hydroxylase pathway, or longer chain 
AR might be poorer substrates for ω-oxidation and thereafter less able to compete 
for the enzyme binding (Ross et al. 2004b). High intake of AR (4 g/kg diet) in rats 
caused decreased (47%, p < 0.001) liver cholesterol concentrations and reduced 
the percentage of cholesterol (35%, p < 0.05) in liver lipids compared to a diet with 
no AR (Ross et al. 2004a). 
 
Effects on growth 
AR were previously regarded as antinutritional components in rye. Ross et 
al. reviewed the studies carried out to examine animal growth with rye-based diet 
(Ross et al. 2004b). Two studies with high AR intake concentrations linked AR 
with decreased growth of rats and pigs (Sedlet et al. 1984, Wieringa 1967). Two 
other studies with similar AR concentrations showed no changes in the growth of 
rats, when they were fed a diet fortified with purified AR compared to a control diet 
with no AR (Bock et al. 1981, Ross et al. 2004a). Animal growth inhibition with 
high rye intake was thought to be due to rye soluble fibre fraction, mostly 
arabinoxylan, instead of AR (Ross et al. 2004b, Vinkx and Delcour 1996). No 
direct cytotoxicity was seen with AR (Rejman and Kozubek 2004). Rats have 
tolerated AR C15:0 up to 5 g/kg body weight (Suresh and Kaleysa 1990). For 
resorcinol LD50 acute oral dose has varied from 300 to 980 mg/kg (Lynch et al. 
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2002). Ross et al. speculated if possible tissue accumulation of AR exists that 
could lead to high AR concentrations in body (Ross et al. 2004b), but no evidence 
exists that this could present any health risks for humans if AR are consumed as a 
normal part of the diet. 
 
1.4 Absorption and metabolism of lipophilic compounds, with 
vitamin E as an example 
 
Lipophilic compounds, such as vitamin E and AR, with high log10 octanol-
water partition coefficients are easily incorporated into oil and probably behave in 
a similar manner in the gastrointestinal tract (Borel 2003, Sakaeda and Hirano 
1998). Such highly lipophilic food microconsituents are absorbed in duodenum via 
the lymphatic system, secreted in chylomicrons, and transported to liver. The 
absorption is variable, and the concentrations measured depend on dose, matrix 
where they are introduced into the bowel, and the method of absorption 
measurement. Absorption is assumed to follow the same intraluminar events as 
for the major dietary lipids, which are emulsification, solubilisation in micelles, 
diffusion across the unstirred water layer, and permeation through the enterocyte 
membrane. The acidic environment in the stomach can liberate the lipophilic 
compounds from the food matrix (. Dietary lipids can affect the absorption  of 
other lipophilic compounds by facilitating the release of the compounds from the 
matrix by providing a hydrophobic phase, stimulating biliary secretion and micelle 
production, and increasing their solubility into micelles, and by inducing 
chylomicron synthesis and thereafter enhancing transport of the compounds from 
enterocytes. Other factors affecting absorption of lipophilic compounds are the 
structure of the compound, molecular linkages, amounts consumed, and 
individual metabolism (Borel 2003). 
 
Metabolism of lipophilic tocopherols and tocotrienols (vitamin E) has been 
examined extensively. They are absorbed unesterified from the small intestine 
after incorporation into micelles in the presence of bile salts and pancreatic 
enzymes, incorporated into chylomicrons and secreted into lymph. Chylomicron 
remnants formed by lipoprotein lipase hydrolysis from triacylglycerols are taken up 
by the liver and thereafter secreted in VLDL. Some vitamin E from chylomicrons 
and VLDL is transferred to peripheral cells, e.g. to liver, skeletal muscle and 
adipose tissue, and to HDL, and some ends up in LDL via VLDL and HDL 
metabolism (Bjørneboe et al. 1990, Hacquebard and Carpentier 2005). LDL and 
HDL are the main vitamin E carriers (Behrens et al. 1982, Hall et al. 2005). In 
women, HDL contained more α-tocopherol than LDL, while the opposite was seen 
in men. VLDL had the greatest capacity to carry α-tocopherol (µg/mg protein) but 
it is present only in small amounts in fasting plasma (Behrens et al. 1982, Cohn et 
al. 1992). There is transfer of α-tocopherol between LDL and HDL, while VLDL 
and chylomicrons are poorer donors of α-tocopherol (Cohn et al. 1992). To get 
more reliable information of individual vitamin E status in human subjects and to 
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take into account the variations of carrier lipoprotein concentrations, it has been 
recommended that plasma tocopherol concentrations should be related to plasma 
lipid concentrations (Horwitt et al. 1972). Vitamin E is secreted into bile, and also 
metabolised into water-soluble products and secreted into urine (Birringer et al. 
2001, Bjørneboe et al. 1990, Frank 2005). For vitamin E, the plasma 
concentrations reflect vitamin redistribution of the newly absorbed vitamin E rather 
than absorption, and there is a lack of dose-dependent increase in plasma 
concentrations. It is not known if there is a limit for vitamin E absorption (Borel 
2003).  Vitamin E uptake varies widely between individuals even when it is rather 
stable for one individual over time (Roxborough et al. 2000). The ratios of 
distribution of α-tocopherol and γ-tocopherol in plasma lipids (µmol/g) and 
erythrocytes (µmol/l) were 0.80 and 0.67, respectively (Lehmann et al. 1988). It 
has been suggested that erythrocyte vitamin E status might be more sensitive 
compared to plasma concentrations to predict individual susceptibility to oxidative 
stress and atherosclerosis (Simon et al. 1998). The molecular structure of vitamin 
E resembles that of AR, and it can be assumed that AR behave in a similar 
manner as vitamin E during absorption and transportation in plasma. 
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2 Aims of the study 
 
Alkylresorcinols (AR) are phenolic lipids that exist in high amounts in the 
outer layers of wheat and rye grains and in processed whole-grain products. It has 
been suggested that AR could function as specific biomarkers for whole-grain 
intake in human diet. Such a biomarker is needed to get precise information of 
whole-grain intake and to elucidate the effects of whole-grain consumption on 
human health. Several biological functions, determined mainly in vitro, are 
described for AR, and the effects are mostly seen in biological membranes, where 
AR are incorporated in vitro due to their lipophilic nature. AR have attracted 
increasing interest as potential biomarkers and as bioactive compounds in human 
nutrition. In this work, AR usability as biomarkers, their occurrence in human 
subjects, and AR absorption in pigs were investigated. 
 
The aims of the present study were: 
 
1. To develop a quantitative gas chromatographic-mass spectrometric 
method for the determination of AR in plasma (Study I). 
 
2. To measure AR concentrations in human plasma after the intake of high-
fibre whole-grain rye bread or low-fibre wheat bread compared to the 
habitual Finnish diet, and to compare the concentrations to the serum ENL 
concentrations in postmenopausal women (Study II). 
 
3. To determine AR incorporation into human erythrocyte membranes ex vivo 
and to measure their concentrations in the membranes after the intake of 
whole-grain products (Study III). 
 
4. To evaluate AR absorption and elimination kinetics in pig plasma and to 
measure the absorption of AR after constant intake of whole-grain rye or 
whole-grain wheat bread and after a whole-grain rye bread bolus in pigs 
(Study IV). 
5. To analyse AR concentrations in plasma, erythrocytes, and lipoproteins ex 
vivo after the intake of whole-grain rye or wheat crisp bread compared to 
low-fibre wheat bread, and to compare plasma AR concentrations to serum 
ENL concentrations (Study V). 
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3 Materials, study designs, and methods 
 
3.1 Human studies 
 
3.1.1 Analysis of human plasma alkylresorcinols after intake of 
whole-grain rye bread compared to low-fibre wheat bread 
(Study II) 
Subjects 
This study was part of a larger study in which the effects of fibre-rich rye 
bread on glucose and lipid metabolism, and on insulin metabolism were examined 
(Juntunen et al. 2003). The study comprised 39 post-menopausal healthy women 
59±0.94 (mean±SEM) years old with a body mass index (BMI) of 26.8±0.5 kg/m2. 
Postmenopausal women were selected because of an increased susceptibility to 
type II diabetes mellitus. The inclusion criteria were elevated serum total 
cholesterol concentration (5.0-8.5 mmol/L), non-HDL-cholesterol 3.5-6.5 mmol/L, 
and BMI 20-33. The subjects did not have diabetes mellitus or diseases that could 
affect lipid metabolism or the function of bowel and they did not use any 
medication (lipid lowering medication, laxatives, or corticosteroids) for such 
conditions. Serum follicle stimulating hormone concentrations were used to 
determine the postmenopausal status.  
 
Study design and diets 
The subjects were advised to keep their body weight and lifestyle habits, 
such as exercise, alcohol consumption, and smoking, as well as regular 
medication constant during the study. They were instructed not to use any 
cholesterol-lowering foodstuffs, probiotics, or products affecting bowel function. 
During the run-in period before the study, the subjects kept a 4 day food record to 
determine average energy intake. The study design (2x8 weeks randomized 
crossover intervention with an eight-week wash-out period) and the dietary advice 
given to the participants have been previously described together with the whole 
study (Juntunen et al. 2003).  
 
All breads were baked in Fazer Bakeries Ltd. (Vantaa, Finland) and 
Vaasan & Vaasan Oy (Helsinki, Finland) bakeries. High-fibre rye bread (17% of 
dietary fibre) portions weighed 24.1-28.1 g and low-fibre wheat bread (2.8% of 
dietary fibre) portions 20.8-25.0 g. One portion of rye bread contained 206 kJ 
(range 174-234 kJ) energy and 4.4 g (4.1-4.6 g) of fibre, and a portion of wheat 
bread 241 kJ (233-249 kJ) energy and 0.6 g (0.5-0.8 g) of fibre. AR contents of 
the breads were not determined. Minimum bread intake was 4-5 portions of the 
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test bread. No maximum for bread intake was set, but subjects were advised to 
eat bread according to their normal cereal consumption and to keep the intake of 
cereal products constant. During the bread periods subjects replaced all bread 
and cereal products in their diet with the test bread so that the energy from bread 
was at least 20% of the total daily energy. Subjects were allowed to eat one 
additional portion of wheat or rye cereal products (sweet pastry or porridge) per 
day during both bread periods, and rice and pasta according to their normal eating 
habits. The portion was recommended to be rye-based product during the rye 
bread period and wheat-based product during the wheat bread period, but this 
was not obligatory. Apart from cereal products subjects were instructed to follow 
their normal eating habits during the follow-up. Dietary compliance was followed 
by food records. Over-night fasting blood samples were taken before and after 
each period, and plasma AR and serum ENL concentrations were analysed. The 
nutritional composition of test breads was analysed at VTT Biotechnology (Espoo, 
Finland). The Ethics Committee of Kuopio University Hospital, Kuopio, Finland 
approved the study. 
 
3.1.2 Incorporation of alkylresorcinols into erythrocyte membranes 
(Study III) 
This was a pilot study, in which nine volunteers participated. Four of them 
(Group I) avoided rye, wheat and barley products for one week and then 
continued for another week with their habitual Finnish diets, including whole-grain 
rye bread (average 3.5 pieces per d) and whole-grain wheat bread rich in AR (2 
pieces per d). Four subjects (Group II) followed their normal diets with whole-grain 
rye (2 pieces per d) and whole-grain wheat bread (2 pieces per d) for two weeks, 
and one subject maintained a gluten-free diet with no rye, wheat or barley 
products. The breads were commercially available whole-grain wheat and rye 
bread. Overnight fasting blood samples were drawn after the first and the second 
week of the experiment and plasma and erythrocyte AR concentrations were 
analysed. The Ethics Committee for the Department of Medicine, Helsinki 
University Central Hospital, Helsinki, Finland approved the study. 
 
3.1.3 Distribution of alkylresorcinols in human plasma, erythrocytes, 
and lipoproteins (Study V) 
Subjects 
Eight women and seven men, age 24.9±1.2 years (mean±SEM) and BMI 
24.4±0.99 kg/m2, participated in the study. The exclusion criteria were diseases or 
medication affecting bowel function, plasma lipoproteins, or erythrocytes, 
antibiotics taken within three months before the study, serious chronic illnesses, 
and alcohol abuse. Haemoglobin had to be above 125 g/l for women and 135 g/l 
for men. 
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Study design and diets 
The study was a 2x1 week randomized crossover study with one-week 
wash-out periods before the study weeks. Subjects were instructed to eat 8 
pieces (100 g) of whole-grain wheat (wheat diet, WD) or whole-grain rye crisp 
bread (rye diet, RD) per day during the test bread periods. During the wash-out 
periods they consumed soft low-fibre (non-wholegrain) wheat bread (LF I and LF 
II). Subjects were allowed to eat one portion of white low-fibre product, such as 
pasta, but not any additional bread or any other whole-grain cereal products other 
that the study breads, during the follow-up. Otherwise their dietary habits were not 
changed. Energy, protein, carbohydrate, fat, and fibre contents were 1300 
kJ/100g DM, 8.7 g/100g DM, 64 g/100g DM, 2.1 g/100g DM, 17 g/100g DM for rye 
crisp bread, and 1500 kJ/100g DM, 11 g/100g DM, 66 g/100g DM, 5.9 g/100g DM, 
10 g/100g DM for wheat crisp bread. Whole-grain flour content was 72% of DM for 
rye crisp bread and 48% of DM for wheat crisp bread. AR homologue content for 
whole-grain rye crisp bread was C17:0 148 µg/g DM, C19:0 275 µg/g DM, C21:0 
145 µg/g DM, C23:0 69 µg/g DM, and C25:0 53 µg/g DM, total AR 690±15.8 µg/g 
DM and for whole-grain wheat crisp bread C17:0 14.4 µg/g DM, C19:0 138 µg/g 
DM, C21:0 118 µg/g DM, C23:0 26.9 µg/g DM, and C25:0 10.7 µg/g DM, total AR 
308±5.1 µg/g DM. Soft low-fibre bread contained 1150 kJ/100g of energy, 10 
g/100 g of protein, 47 g/100 g of carbohydrates, 4.8 g/100g of fat, and 3.8 g/100 g 
of fibre. It contained no whole-grain flour, and contained no AR. All breads were 
provided by Vaasan & Vaasan Oy (Espoo, Finland).   
 
Over-night fasting blood samples were taken after WD, RD, LF I, and LF II, 
and plasma, erythrocyte, and lipoprotein AR concentrations, serum ENL 
concentrations, and serum α- and γ-tocopherol and retinol concentrations were 
analysed. Haemoglobin, blood cells, and lipoprotein fractions were measured from 
all samples. In addition, plasma AR and serum ENL concentrations were analysed 
after habitual diet before the study and one week after the study. Subjects 
recorded the intake of the breads and any other cereal products during the study. 
The Ethics Committee for the Department of Medicine, Helsinki University Central 
Hospital, Helsinki, Finland approved the study. 
 
3.2 Animal studies 
 
3.2.1 Kinetics of alkylresorcinols in pig plasma (Study IV) 
Pigs 
The experimental part of the study was carried out by Prof. K.E. Bach 
Knudsen’s research group at the Department of Animal Health, Welfare and 
Nutrition, Danish Institute of Agricultural Sciences, Foulum, Tjele, Denmark. Four 
male castrated pigs from the Danish Institute of Agricultural Sciences’ Swine herd, 
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Foulum, Denmark with an initial body weight of 44.6±2.4 kg were used in the 
study.  
 
Study design and diets 
The study comprised two parts, Part 1 and Part 2. Two experimental diets 
with soft and crisp wheat bread (WD) and soft and crisp whole-grain rye bread 
(RD) were used in the studies. Soft breads were produced by Nordmills Cerealia 
AB (Malmö, Sweden) and crisp breads by Wasa Bread AB (Filipstad, Sweden). 
Rye crisp bread contained whole-grain rye flour, rye bran (Wasa T2), fat, salt, and 
wheat crisp breads white wheat flour, purified wheat fibre (essential cellulose, 
Vitacel WF 600, Rettenmair and Söhne, Ellwagen-Holzmühle, Germany), sugar, 
salt, and dry malt as main ingredients. WD and RD were balanced with vitamins 
and minerals, and provided 19, 15, and 66% of energy from fat, protein, and 
carbohydrates, respectively.  There was 119 g/kg DM of protein, 68 g/kg DM of 
fat, 773 g/kg DM of carbohydrates, and 230 g/kg DM of dietary fibre in WD and 
127 g/kg DM of protein, 73 g/kg DM of fat, 699 g/kg of carbohydrates, and 237 
g/kg DM of fibre in RD. WD did not contain any AR. RD contained AR 
homologues C17:0 262 µg/g DM, C19:0 372 µg/g DM, C21:0 284 µg/g DM, C23:0 
134 µg/g DM, and C25:0 106 µg/g DM, with a total amount of 1158 µg AR/g DM. 
 
Each pig was surgically fitted with two catheters, one in the portal vein and 
the other in the mesenteric artery. The pigs were given Streptocillin up to 4 days 
after the surgery. Up to one week before surgery pigs were fed a diet made of 
wheat, barley, and soybean (AR content 54 µg/g DM). The last week before 
surgery and 10 days after the surgery pigs were fed whole-grain rye diet with 
casein, vitamins, and minerals (873 g whole-grain rye/d, AR content 655 µg/g 
DM). After this the pigs were gradually introduced to experimental diets in a cross-
over design (Part 1). The pigs were fed either rye (1250±15 g DM/day 
(mean±SEM)) or wheat (1250±24 g DM/day) bread in equal amounts three times 
daily (at 07.00, 15.00, and 22.00 hours) in a cross-over design. Portal and arterial 
samples were collected on days 5 and 7 at -30, 0, 30, and then at 60 min intervals 
up to 540 min. Pigs were fed again at 480 min. After this trial, the pigs were fed a 
semi-synthetic diet with wheat starch (707 g/kg), cellulose (80 g/kg), casein (182 
g/kg), and vitamins and minerals (28 g(kg) with no AR for 4 days, deprived of food 
for 24 hours and then given one portion of RD (492 g DM) (Part 2). Blood samples 
were taken at -30, 0, 30, and then at 60 min intervals up to 960 min, after which 
the pigs were fed RD. The study was repeated the following week. The pigs in 
Part 2 with exception of one were the same as in Part 1. The experiment followed 
the guidelines of the Danish Ministry of Justice. 
 
The study designs of the human and animal studies are summarised in 
Table 2. 
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Table 2. The study designs of human (Study II, III, and V) and animal studies (Study V). 
 
 
*DM=dry matter 
Study 
Number 
of 
subjects 
Age 
(years) BMI Test breads Bread intake 
Study 
design Wash-out period 
Wash-
out 
duration 
II 39 59±0.94 26.8±0.5 
Low-fiber wheat/ 
whole-grain rye 
bread 
178±6.5/ 
214±7.1 g/d 2x8 weeks Habitual Finnish diet 8 weeks 
III 
Group I 
4 nd nd 
Whole-grain rye/ 
whole-grain wheat 
bread 
nd 1x1 week 
Low-fiber wheat 
bread diet 
1 week 
III 
Group II 
4 nd nd 
Habitual Finnish 
diet 
nd 2 weeks - - 
V 15 24.9±1.2 24.4±0.99 
Whole-grain wheat/ 
whole-grain rye 
crisp bread 
95.5±2.1/ 
97.5±0.97 g/d 1x1 week 
Low-fiber wheat 
bread diet 
1 week 
IV 
Part I 
4 pigs - - 
Low-fiber wheat/ 
whole-grain rye 
diet 
1250±15/ 
1250±24 g DM*/d 1x1 week 
Whole-grain rye 
diet 
10 days 
IV 
Part II 
4 pigs - - Whole-grain rye 
diet 
492 g single 
feeding 
Semi-synthethic low-
fiber wheat diet 
5 days 
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3.3 Methods 
 
3.3.1 Solvents and reagents 
Methanol and n-heptane were obtained from Rathburn Chemicals Ltd. 
(Walkerburn, Scotland). Acetic acid, diethyl ether, sodium chloride, copper 
sulphate and sodium hydroxide were purchased from Merck KGaA (Darmstadt, 
Germany). Trimethylchlorosilane (TMCS) and hexamethyldisilazane (HMDS) were 
obtained from Pierce Chemical Co. (Rockford, IL, USA). DEAE 
(diethylaminoethyl) -Sephadex A-25 and Sephadex G-25 were purchased from 
Pharmacia Biotech AB (Uppsala, Sweden), pyridine from Romil Ltd. (Waterbeach, 
Cambridge, UK), and EDTA was from Sigma-Aldrich Co (St. Louis, MO, USA). 
Buffers were prepared at the HUSLAB, Hospital District of Helsinki and Uusimaa, 
Helsinki, Finland. A standard sample used in retinol and tocopherol analysis was 
a certified serum standard (SRM 968a, National Institute of Science and 
Technology, Gaithersburg, MD, USA) . 
 
3.3.2 Alkylresorcinol reference compounds 
5-n-Alkylresorcinols (C15:0, C17:0, C19:0, C21:0, C23:0 and the internal 
standard C20:0) were prepared by M.Sc. K. Parikka in Prof. K. Wähälä’s group, 
Department of Chemistry, University of Helsinki, or purchased from 
ReseaChem Life Science, Burgdorf, Switzerland. 
 
3.3.3 Instrumentation 
The gas chromatography-mass spectrometry (GC-MS) instrument was a 
Fisons instrument MD 1000 quadrupole mass spectrometer combined with a 
Fisons GC 8000 gas chromatograph (Fisons Instruments, Manchester, UK). The 
column used was a 12 m BP-1 column from SGE (SGE International Pty. Ltd, 
Australia) with film thickness of 0,25 µm and internal diameter of 0,22 mm. Helium 
was used as the carrier gas with a flow rate of 1 ml/min. The temperature of the 
column was kept at 150 °C for 1 minute, then raised 40 °C/min to 230 °C and 
further 9 °C/min to 290 °C, where it was kept for 2 minutes, then raised 12 °C/min 
to 300 °C, where it was kept for 6 minutes. The temperatures of the injector and 
the ion source were 300 °C and 250 °C respectively. The interface temperature 
was 270 °C. The ionization energy was 70 eV.  The splitless injection volume of 
the sample was 1 µl. After one minute splitless time, the split-ratio was 1:30. 
Plasma lipoproteins, triacylglycerols, and proteins were measured from serum by 
Konelab 60i (Thermo Electron Corporation, Waltham, MA, USA). Haemoglobin 
and blood cells were measured from blood by Sysmex KX-21 (TOA Medical 
Electronics Co., LTD, Kobe, Japan). Haematocrit measurement from erythrocyte 
suspensions was performed with Adams Autocrit Centrifuge (Clay-Adams Inc., 
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New York, USA). Lipoprotein ultracentrifugation was performed with Beckman 
Optima LE-80K ultracentrifuge with Ti 50.4 rotor. Serum ENL was analysed with 
AutoDELFIA 1235 Automatic Immunoassay System (Wallac Oy, Turku, Finland). 
 
3.3.4 Isolation of lipoproteins 
VLDL (density 1.006 g/ml), LDL (density 1.019-1.063 g/ml), and total HDL 
(density 1.063-1.21 g/ml) were isolated from 3 ml of plasma by sequential 
ultracentrifugation as previously described (Havel et al. 1955, Höckerstedt et al. 
2002). Samples were stored at -80 °C until further analysis. Lipoprotein fractions 
(sample volume 2 ml) were purified, and EDTA, unbound AR, and other small 
molecular weight compounds were removed by size exclusion gel filtration with 
Sephadex G-25 column (1x20 cm) and eluting with phosphate buffered saline (pH 
7.4) (Helisten et al. 2001). A method by Lowry et al. was used to measure the 
protein concentrations of the collected fractions (Lowry et al. 1951). 
  
3.3.5 Quantitative analysis of alkylresorcinols 
Plasma 
An internal standard AR C20:0 in methanol (1.8 µg/ml, 20 µl) was added 
into 500 µl of plasma and the samples were incubated with 500 µl of ionized water 
at +37 °C overnight and extracted three times with 3 ml of diethyl ether and 
vigorous shaking with a Vortex mixer. Organic phases, separated by freezing the 
water phase, were collected and evaporated to dryness, and purified with an ion-
exchange chromatography with DEAE–Sephadex A-25 column (column 
dimensions 0.5x1.5 cm) in a free base form (Fotsis and Adlercreutz 1987). The 
sample was applied to the column in 2x300 µl of methanol and neutral steroids 
were eluted with 6 ml of methanol and discarded. Alkylresorcinols were collected 
by eluting the column further with 6 ml of 0.1 M acetic acid in methanol. This 
fraction was evaporated to dryness and th samples were derivatised with 
silanising agent (pyridine: HMDS:TMCS 9:3:1 (v:v:v)). Ions with m/z 464, 492, 
520, 534, 548, and 576 for alkylresorcinols C15:0, C17:0, C19:0, C20:0, C21:0, 
and C23:0, respectively, were monitored and used for quantitative determinations. 
In addition an ion with m/z 604 was used for the detection of the alkylresorcinol 
C25:0 in plasma. An ion with m/z 268 for all alkylresorcinols was used as a 
confirmatory ion where necessary. Quantification of alkylresorcinols was done by 
relating the peak area of the analyte to the peak area of the internal standard (AR 
C20:0) in the sample. Standards with known amounts of alkylresorcinols were 
analysed in the same way. Based on the measured peak area ratio of the 
standard and the known amount of alkylresorcinol in the standard mixture, a linear 
graph was drawn. The equation for the line was used to calculate the amount of 
each alkylresorcinol in the sample. The method was validated for the 
quantification of alkylresorcinols C15:0, C17:0, C19:0, C21:0, and C23:0. The 
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standard graph for alkylresorcinol C23:0 was used for the quantification of the 
alkylresorcinol C25:0. 
 
Erythrocytes 
Erythrocytes were analysed with a modified method for the analysis of 
tocopherols (Bieri et al. 1979, Linko and Adlercreutz 2005, Simon et al. 2001). 
Erythrocytes were separated from plasma by centrifugation (3500 x g, 10 min, 10 
°C). In Study III the cells were washed three times with 0.15 M NaCl in 10 mM Na-
phosphate buffer, pH 7.4, and made to a 50% haematocrit suspension. Samples 
were stored at -20 °C until analysis. An internal AR standard C20:0 was added to 
3 ml of suspension and proteins were denaturated with 5-7 ml ice-cold methanol 
and vigorous shaking. AR were extracted twice with 10 ml n-heptane, which was 
evaporated to dryness. In Study V erythrocytes were washed three times with 
0.9% NaCl-solution. The washing solution was removed and 1 ml of cells was 
pipetted, into which 1 ml of 2 mmol/l EDTA-solution was added. The cells were 
stored at -80 °C. An internal standard C20:0 was added and proteins were 
denaturated by adding 5 ml of methanol and shaking. In both studies AR were 
extracted three times with 7 ml of n-heptane. After extraction, the samples were 
dissolved into 0.5 ml of methanol and purified with DEAE-Sephadex A-25 (column 
dimensions 0.5x1.5 cm) in a free base form, and analysed with the GC–MS as 
with the plasma method. 
 
Lipoproteins 
VLDL, LDL, and HDL AR concentrations were analysed otherwise similar 
to the plasma method, but they were extracted four times with 4 ml diethyl ether to 
achieve better extraction recovery. 
 
Test breads 
The analysis of AR in breads was performed by PhD A. Ross (Study IV) 
and by MSc R. Landberg (Study V) in Prof. P. Åman’s research group at 
Department of Food Science, Swedish University of Agricultural Science, 
Uppsala, Sweden. AR were analysed by GC, and GC-MS where necessary (Ross 
et al. 2001a, Ross et al. 2003c).  
 
3.3.6 Serum enterolactone 
Serum ENL concentrations were measured by a time-resolved 
fluoroimmunoassay (Adlercreutz et al. 1998, Stumpf et al. 2000b). [6,7-3H]-
estradiol-17-glucuronide was used as an internal standard. Unconjugated ENL 
was extracted with diethyl ether from the samples after overnight incubation with 2 
M sulphatase and 0.2 M β-glucuronidase. The samples with assay buffer, 
antiserum in bovine serum albumin (dilution 1:250 000), and europium-labelled 
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ENL derivative (dilution 1:400 000) were added on prewashed goat anti-rabbit IgG 
microstrips and analysed with the AutoDELFIA 1235 Automatic Immunoassay 
System.  
 
3.3.7 Other analytical methods 
Retinol, and α- and γ-tocopherol analysis was done at Prof. Georg Alfthan’s 
laboratory at the Department of Epidemiology and Health Promotion, National 
Public Health Institute, Helsinki, Finland. Ethanol solution (50%, 800 µl) with 
ascorbic acid, butylated hydroxytoluene, and tocol as an internal standard for 
tocopherols was added to the sample (100 µl), and the samples were mixed and 
analytes were extracted with 1 ml hexane. An aliquot of 800 µl was evaporated to 
dryness under nitrogen and redissolved in 100 µl methanol. An Inertsil ODS-3 
column (2.1x100 mm, 3 m, GL Sciences, Japan), with methanol as the mobile 
phase (0.3 ml/min, injection volume 5 µl), was used to separate α- and γ-
tocopherols. Tocopherols were detected using peak height tocol -ratios by their 
fluorescence at 292/324 nm. Retinol was detected in a similar way at 325 nm. 
Plasma standard sample traceable to a certified serum standard was used as a 
control for tocopherols and freshly prepared all-retinol standards in ethanol was 
used as a control for retinol. 
 
3.3.8 Quality assurance 
Two to three pooled control plasma samples, either pooled plasma from 
the Finnish Red Cross or pooled plasma from other studies, were included in 
every plasma analysis batch together with a blank sample of water. For 
erythrocytes duplicates of a control sample, which was a sample from one person 
in Study III and a sample pooled from one day samples from all subjects in Study 
V, and a blank sample were included in every batch. In lipoprotein AR 
measurements we used two pooled LDL-samples from other studies together with 
a blank sample. If the blank sample contained any AR, the whole batch was 
reanalysed. Plasma and erythrocyte samples were analysed as duplicates, but 
due to the scarcity of the sample material, lipoprotein AR were analysed as single 
measurements. In ENL analysis, duplicates of three control samples with different 
concentrations were analysed. In all analyses, if control samples exceeded±2SD 
of the total average value of the analysed samples, the analysis was repeated. If 
the coefficient of variation (CV) for duplicate analytes deviated more than 15%, 
the sample was reanalysed. 
 
3.3.9 Assessment of pharmacokinetic parameters 
The pharmacokinetic parameters calculated in Study III were maximum 
plasma concentration (Cmax), time of peak concentration observed (tmax), area 
under the plasma concentration time curve from 0 to 8 or 15 h (AUC0–8 h/AUC0–15 
h) corrected for baseline (0 h), the elimination half-life, and the absorption half-life. 
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The parameters were calculated with PK Solutions 2.0 Noncompartmental 
Pharmacokinetics Data Analysis program (Summit Research Services, Montrose, 
CO, USA).  
 
3.3.10 Statistical analysis 
The normality of the data was tested with Shapiro-Wilk’s test. A correlation 
analysis was done with Spearman’s rho. Non-parametric statistics (Friedman’s 
test followed by Wilcoxon’s signed rank test) were used to determine the 
between-group and within-group differences in the studies. When data was 
normally distributed, paired samples T-test and general linear model with 
repeated measures were used to test differences in study groups. Statistical 
analysis was performed with SPSS 11.0.1 (SPSS Inc., Chicago, IL, USA) or with 
Minitab version 11 (State College, PA, USA). Differences were considered 
significant at the 95% confidence level (p < 0.05). Results are expressed as 
mean±SEM, and as a sum of AR homologues C17:0-25:0, unless otherwise 
stated. 
 
4 Results 
 
4.1 Analytical methods for alkylresorcinols in plasma, 
erythrocytes, and lipoproteins (Study I, II, III, IV, and V) 
 
Plasma 
Analysis of plasma AR consists of sample incubation with water, extraction 
of the analytes, purification of the sample by ion-exchange chromatography, and 
analysis by gas chromatography-mass spectrometry. Incubating the samples with 
enzymes β-glucuronidase (0.1 U/ml) or sulphatase (1 IU/ml) did not improve the 
yield compared to overnight incubation with water. However, the overnight 
incubation gave higher yields and better precision compared to shorter incubation 
(3 h), but with a 36 h incubation no improvement in the results was seen. Diethyl 
ether, petroleum ether, ethyl acetate, n-hexane, and mixtures of n-hexane:ethyl 
acetate (1:3 and 4:1 (v:v)), n-hexane:diethyl ether (1:1 and 1:3 (v:v)), and diethyl 
ether:ethyl acetate (1:1 and 4:1 (v:v)) were tested as the extraction solvents. 
Diethyl ether gave the best extraction recovery of the analytes. We tested DEAE-
Sephadex (column dimensions 0.5x3 cm) in acetate form and Sep-Pak C18 solid 
phase extraction (Waters Co., Milford, MA, USA) in addition to DEAE-Sephadex 
(column dimensions 0.5x1.5 cm) in a free base form in sample purification. Poor 
recovery of AR was found with Sep-Pak C18 or DEAE-Sephadex in acetate form, 
and the analytes were eluted in several fractions, probably due to binding of AR to 
the column. 
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AR-free plasma either from a person following a gluten-free diet or carbon-
treated plasma removing AR was used when the recoveries were tested. The 
mean recovery for all alkylresorcinol standards was 112±10.8% (mean±SD).  Limit 
of detection was 2.1-3.3 pg and limit of quantification 4.1-6.5 pg on column. The 
range of linearity was up to 230, 270, 220, 650, and 210 pg per injection and up to 
22.8, 26.6, 32.2, 32.6, and 30.8 ng in a sample for AR C15:0, C17:0, C19:0, 
C21:0, and C23:0, respectively. Most of the analysed samples fitted to this range. 
If the sample AR concentration was higher, it was diluted and reanalysed. C25:0 
could not be tested, since we did not have a reference compound for that 
compound. C23:0 was used to quantify C25:0. 
 
A sample chromatogram of plasma AR and the respective AR standards is 
presented in Figure 2. With whole-grain rye diet, in front of AR homologue peaks 
C19:0, C21:0, C23:0, and C25:0 smaller peaks with the same base ion fragment 
(m/z 268) as for AR are seen. These are monounsaturated derivatives of AR. 
Similar peaks have also been detected in cereal samples (Ross et al. 2004c). Due 
to the lack of reference compounds and small amount of these compounds in the 
samples, we did not quantify these peaks. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Total ion current chromatogram of alkylresorcinols in a standard mixture 
and in a plasma sample from the same person after whole-grain wheat and rye diets. The 
dashed arrows point to the unsaturated derivatives of alkylresorcinols C19:0, C21:0, 
C23:0, and C25:0 in plasma. 
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Erythrocytes and lipoproteins 
At first erythrocytes were separated from blood and the cell membranes 
were isolated with hypotonic lysis (Clark and Switzer 1977, Hanahan and Ekholm 
1974). AR concentrations were similar to those of washed whole erythrocytes 
indicating that AR are incorporated into the cell membranes. In Studies III and V 
the two different washing solutions (0.15 M NaCl (0.9%) in 10 mM Na-phosphate 
buffer and 0.9% NaCl-solution) did not cause any difference in the results. In 
Study V the washed erythrocytes were pipetted, which seemed to be more 
precise than preparing and measuring a 50% haematocrit solution as was done in 
Study III. Erythrocyte AR extraction was tested with diethyl ether and n-heptane. 
Diethyl ether was difficult to separate from buffer-methanol solution, and n-
heptane therefore gave better analyte recoveries and was used in the analyses. 
After washing the cells and protein denaturation with MeOH the analysis method 
was similar to that of plasma analysis, except for the extraction solvent. With 
lipoprotein analysis the extraction with diethyl ether was performed four times to 
increase the yield of AR. Otherwise the method was the same as for plasma AR. 
The actual recoveries after addition of reference compounds could not be 
performed for erythrocyte or lipoprotein samples, since added AR would not have 
been incorporated into the erythrocyte membranes or lipoproteins, which would 
have affected the recoveries and would not have given data comparable to 
samples acquired in vivo. 
 
Precision 
Intra-assay CV for analysis of AR in plasma samples was <10% (n=10) 
during method development (Study I), and <10% in Study II and III, 10% in Study 
IV, and <10% in Study V. For ENL, intra- and inter-assay precision was <10% in 
Studies II and V. In Study V for erythrocytes, intra-assay precision was 5% (n=10). 
Interassay coefficients of variation are presented in Table 3. In Study V, the inter-
assay CV for lipoproteins was 20%.  
 
 
Table 3. Inter-assay precision of alkylresorcinol analysis in plasma, erythrocytes, 
and lipoproteins. 
 
 
 
 
 
 
 
 
Study 
 AR  
(nmol/l or 
nmol/l packed cells) 
CV 
(%) 
Number of 
assays 
Study I (Plasma) 344 9.6 7 
Study II (Plasma) 249 15.2 7 
Study III (Plasma) 172 7.0 2 
Study IV (Plasma) 189 15.0 12 
Study V (Plasma) 466 11.9 4 
Study V (Erythrocytes) 178 10.8 8 
Study V (Lipoproteins) 4 20 23 
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4.2  Kinetics of alkylresorcinols in pigs (Study IV) 
 
Arterial and venous AR concentrations were similar (r2=0.96, p < 0.05) in 
all measurement time points when the pigs ate rye diet on habitual basis for 5 to 7 
days (Part 1), and when they were fed a single rye bread meal (Part 2). There 
were no clear differences in the absorption of AR homologues C17:0-C25:0 after 
habitual whole-grain rye bread diet (Figure 3) or wheat bread diet (data not 
shown) in Part 1 or after single rye bread feeding in Part 2 (Figure 4). 
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Figure 3. Mean pig plasma alkylresorcinol (AR) homologue (C17:0-C25:0, nmol/l) 
concentrations after habitual rye consumption (Part 1 of Study IV, n=4) measured after 
morning feeding. The arrow shows the second feeding. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Mean pig plasma alkylresorcinol (AR) homologue (C17:0-C25:0, nmol/l) 
concentrations after intake of a single rye bread portion (Part 2 of Study IV, n=4). 
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In Part 1, the maximum AR plasma concentrations varied between the 
pigs, and within the pigs after habitual rye consumption in repeated studies. The 
maximum AR concentrations were 732 and 971, 538 and 895, 744 and 613, and 
1406 and 854 nmol/l for the four pigs, respectively, in repeated studies. The tmax 
varied from 3 to 6 h. The baseline AR concentrations during habitual rye intake 
after a 9-hour food deprivation were 102-772 nmol/l (260±77 nmol/l), being in five 
out of seven cases less than 200 nmol/l. 
 
In Part 2, the individual and between animal variations in peak plasma AR 
concentrations were lower. The maximum concentrations from repeated studies 
were 989 and 913, 500 and 701, 821 and 753, and 605 and 672 nmol/l for the four 
pigs respectively. The tmax was similar in repeated studies for all pigs (3-4 h), 
except for one. The individual curves for the appearance of AR in plasma in Part 2 
are presented in Figure 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Individual appearance of total alkylresorcinols (AR) in plasma (nmol/l) after 
single intake of rye bread in pigs with repeated feedings (Part 2 of Study IV, n=4 with 
repeated studies marked as I and II). 
 
The absorption half-life for total AR was 1.20 h, and the apparent 
elimination half-life 3.93 h. The absorption and elimination half-lives were similar 
for all homologues C17:0-25:0 (1.02-1.57 h and 3.35-3.96 h respectively for 
arterial and venous samples). Half-life duration was not related to AR homologue 
chain length.  The area under the curve was slightly larger when the pigs were fed 
rye diet for the second time in Part 1 and 2 of the study, but the difference did not 
reach statistical significance. Plasma AR baseline concentrations were ~30 nmol/l 
after AR-free diet, although no AR were detected in the diet breads. Before the 
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test diet, the pigs were fed basal diet containing minute amounts of AR. After 
single feeding of the bread during the AR-free diet, AR concentrations in the pigs 
increased up to 74 nmol/l at 180 min. 
 
4.3 Plasma alkylresorcinol and serum enterolactone 
concentrations (Study II, III, IV, and V) 
 
Plasma AR concentrations after the low-fibre diets with little or no AR in 
human subjects (one week in Study III and V, eight weeks in Study II) and in pigs 
(5 days in Study IV) were low. In different studies, the variations in plasma AR 
were large after the habitual diet. However, within the studies with repeated 
periods and measurements the average plasma AR concentrations were similar. 
AR concentrations returned to the baseline after eight weeks with habitual diet in 
Study II after 39 women were fed whole-grain rye or low-fibre wheat diet for eight 
weeks. In Study III AR concentrations remained the same throughout the two-
weeks follow-up with the habitual diet (n=4), and were remarkably lower 
compared to the other studies with habitual diets, being on average at the same 
level as the values of the other four subjects in this same study with low-fibre diet. 
In Study V (n=15) plasma AR concentrations in human subjects were lower after 
the one-week habitual diet at the end of the trial (total of four weeks) compared to 
the concentrations with habitual diet at the beginning of the study. In human 
subjects, the intake of whole-grain rye bread 214±7.1 g/d (n=39, mean±SEM) for 
eight weeks in Study II, and the intake of whole-grain rye crisp bread 97.5±0.97 g 
(n=15, 690 µg AR/g DM) for one week in Study V, increased plasma AR 
concentrations significantly. With pigs in Study IV, the intake of rye bread, 1250 g 
DM/d (1158 µg AR/g DM) for 5-7 days, raised plasma AR concentrations similarly 
as in human subjects. Intake of whole-grain wheat bread, 95.5±2.1 g (n=15, 308 
µg AR/g DM) for one week in Study V, increased plasma AR concentrations about 
half of that with rye bread. See Table 4 for plasma AR concentrations measured 
from fasting samples after the study periods. 
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Table 4. Fasting plasma alkylresorcinol (AR) concentrations (nmol/l) in human 
subjects in Studies II, III, V, and for pigs in Study IV after intake of whole-grain wheat and 
rye breads, mixed whole-grain diet, low-fibre breads, or habitual diet for different periods. 
Values are presented as mean±SEM (range). Two values in the same column in the 
same study show the results from repeated periods within that study. Means in a column 
without a common letter differ (p < 0.05, Wilcoxon signed rank test). 
 
 
Serum ENL concentrations were measured in Study II and V. They 
increased significantly with whole-grain rye bread intake in women (n=39) in Study 
II and in men (n=7) in Study V, but not in women (n=8) in Study V. The values are 
presented in Table 5. 
 
 
 
 
 
 
 
 
 
 
 
Plasma AR 
(nmol/l) 
 
Whole-grain 
wheat bread 
diet 
Whole-grain 
rye bread 
diet 
Mixed  
whole-grain 
bread diet 
Low-fibre 
wheat bread 
diet 
Habitual diet 
Study II 
(n=39, 8 wk) - 
352±24.7a 
(147-766) - 
36.6±4.2b 
(10.9-130) 
97.7±12.0 c/ 
88.3±8.7c 
(34.1-418)/ 
(12.9-245) 
Study III 
(n=4+4,1 wk) - - 
207±54.7a 
(56.3-288) 
32.4±12.2b 
(4.4-55.5) 
37.8±15.4 c/ 
41.2±23.5c 
(10.8-69.0)/ 
(11.0-110) 
Study IV  
(n=4 pigs, 
5-7 d) 
- 
260±93.1a 
(140-537) - 
34.6±4.9b 
(24.2-47.7) - 
Study V 
(n=15, 1 wk) 
107±14.1b 
(34.4-231) 
222±24.5a 
(55.1-389) - 
30.1±10.7 c/ 
25.4±3.0c 
(5.5-171)/ 
(9.6-46.0) 
127±33.9b,d/ 
74.6±17.3d 
(7.5-434)/ 
(11.5-263) 
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Table 5. Serum enterolactone (ENL) concentrations (nmol/l) after intake of whole-
grain wheat or rye bread compared to low-fibre or habitual diet in Study II and V. Values 
are presented as mean±SEM (range). In Study V n=15 represents the combined data 
from women and men. Two values in the same column in the same study show the 
results form repeated periods within that study. Means in a column without a common 
letter differ (p < 0.05, Wilcoxon signed rank test). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In human subjects, individual plasma AR concentrations after the eight-
week (Study II) and one-week (Study V) periods varied widely after the intake of 
whole-grain breads (Figures 6 and 7). Inter-individual variation was remarkable 
even after daily intake of the same amount of breads in Study V (Figure 6). ENL 
serum concentrations also varied after eight-weeks (Study II) and one-week 
(Study V) whole-grain bread periods (Figures 8 and 9). In Figures 7 and 9 plasma 
AR and serum ENL patterns on individual basis during the follow-up are shown 
(Study V, n=15). With AR a clear pattern following the habitual, low-fibre, or 
whole-grain wheat or rye bread diets in almost all individuals during the follow-up 
was seen (Figure 7). Serum ENL concentrations did not change in all subjects 
(n=5 in Study II and n=2 men in Study V) in spite of high intake of whole-grain rye 
bread that is known to be rich in plant lignans from which ENL is produced. In 
certain cases, ENL concentrations decreased with the intake of whole-grain rye 
bread (n=3 in Study II and n=1 woman in Study V).  
 
Serum ENL  
(nmol/l) 
 
Whole-grain 
wheat bread 
diet 
Whole-
grain rye 
bread diet 
Low-fibre bread 
diet 
Habitual diet 
Study II 
(n=39, 8 wk) - 
53.5±10.0a 
(4.4-371) 
22.7±4.0b 
(0.68-150) 
32.8±4.8c/ 
27.1±3.9c 
(0.08-136)/ 
(2.3-127) 
Study V 
(n=15, 1 wk) 
11.4±2.8b 
(0.71-41.3) 
20.6±3.1a 
(1.3-38.7) 
9.7±1.4b/ 
12.1±2.2b 
(0.29-55.9)/ 
(1.6-27.5) 
16.5±3.7a,b/ 
15.9±2.6a,b 
(0.29-55.9)/ 
(0.74-37.0) 
Study V 
Women 
(n=8, 1 wk) 
16.2±3.0 
(5.8-41.3) 
22.8±3.1 
(1.3-38.7) 
12.9±1.1/ 
17.3±2.0 
(7.2-18.7)/ 
(3.3-27.5) 
21.7±4.4/ 
19.5±2.7 
(3.5-55.9)/ 
(6.1-37.0) 
Study V 
Men 
(n=7, 1 wk) 
5.9±1.8b 
(0.71-21.4) 
18.0±3.2a 
(1.4-35.8) 
6.1±1.0b/ 
6.1±1.2b 
(0.76-10.9)/ 
(1.6-14.6) 
10.5±2.2a,b/ 
11.9±2.3b 
(0.29-18.9)/ 
(0.74-25.4) 
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Figure 6. Individual plasma alkylresorcinol (AR) concentrations (nmol/l) in human 
subjects after an eight-week habitual, low-fibre, or whole-grain rye bread diets (Study II, 
n=39). (--) mean of all subjects. 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
  
 
 
 
Figure 7. Individual variation of plasma alkylresorcinol (AR) concentrations (nmol/l) 
in human subjects (Study V, n=15) after habitual, low-fibre, and whole-grain wheat and 
rye bread diets (one-week periods). (--) mean of all subjects. 
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Figure 8. Individual serum enterolactone (ENL) concentrations (nmol/l) in human 
subjects after eight-week habitual, low-fibre, or whole-grain rye bread diets (Study II, 
n=39). (--) mean of all subjects. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Individual variation of serum enterolactone (ENL) concentrations (nmol/l) in 
human subjects (Study V, n=15) after habitual, low-fibre, whole-grain wheat and rye 
bread diets (one-week periods). (--) mean of all subjects. 
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In Study V with human subjects (n=15) mean plasma AR concentrations 
increased significantly with increasing amounts of AR intake after one week AR-
free low-fibre diet, whole-grain wheat bread, and rye whole-grain bread periods (0, 
29, and 67 mg AR/d during LF, WD, and RD) (Figure 10). In Study II plasma AR 
concentrations correlated to whole-grain rye bread intake (r=0.34, p < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Relation of mean plasma alkylresorcinol (AR) concentrations (nmol/l) to 
alkylresorcinol intake after intake of alkylresorcinol-free low-fibre diet (0 mg AR/d), whole-
grain wheat bread (29 mg AR/d) and whole-grain rye bread (67 mg AR/d) (one-week 
periods) with repeated measurements (Study V, n=15). 
 
Plasma AR homologue C17:0/C21:0 -ratio was significantly different after a 
one-week intake of whole-grain wheat and rye breads in Study V compared to 
low-fibre diets or to habitual diet, and after an eight-week intake of whole-grain rye 
compared to low-fibre wheat and habitual diets in Study II (Table 6). 
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Table 6. Alkylresorcinol (AR) homologue C17:0/C21:0 -ratio in plasma after intake 
of whole-grain wheat or rye bread, low-fibre wheat bread, and habitual diets in human 
subjects (Study II and V) and in pigs after constant intake and after single rye bread 
feeding (Study IV). Bread AR C17:0/C21:0 -ratio was measured in Study IV and in Study 
V. Values are presented as mean±SEM (range). Two values in the same column in the 
same study show the results form repeated periods within that study. Means in a column 
without a common letter differ (p < 0.05, Wilcoxon signed rank test). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AR C17:0/C21:0 
 
Whole-grain 
wheat bread 
diet 
Whole-grain 
rye bread diet 
Low-fibre 
wheat 
 bread diet 
Habitual diet 
Study II 
(n=39, 8 wk) - 0.84±0.04
a
 0.53±0.08b 
0.74±0.06c/ 
0.68±0.05c 
Study IV 
(n=4 pigs, 1 wk) - 0.73±1.10
a
 0.47±0.04b - 
Study IV 
(n=4 pigs, 
single feeding) 
- 0.84±0.03 - - 
Study V 
(n=15, 1 wk) 0.10±0.01
 b
 0.60±0.06 a 
0.01±0.01c/ 
0.05±0.03c 
0.28±0.05d/ 
0.52±0.09a,d 
Study IV, bread  0.92   
Study V, bread 
(n=3) 0.12±0.002
b
 1.02±0.01a - - 
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4.4 Alkylresorcinol occurrence in erythrocyte cell membranes 
(Study III and V) 
 
We analysed erythrocyte AR in two studies (Study III and V), and showed 
that AR are incorporated into the cells in vivo. The concentrations decreased 
significantly during one-week low-fibre diets compared to whole-grain diets in both 
studies (Table 7). 
 
 
Table 7. Erythrocyte alkylresorcinol (AR) concentrations (nmol/l packed cells) in 
Studies III and V after one-week intake of whole-grain wheat or rye bread or mixed whole 
grain diet compared to habitual diet or one-week low-fibre diet. Values are presented as 
mean±SEM (range). Two values in the same column in the same study show the results 
form repeated periods within that study. Means in a column without a common letter differ 
(p < 0.05, Wilcoxon signed rank test). 
 
 
In Study III plasma to erythrocyte AR ratio after the intake of whole-grain 
cereals (n=4+4) was 0.7±0.1. The ratio of AR in human plasma and erythrocytes 
was 0.7±0.1 after RD and 0.5±0.1 after WD (one-week periods), and 0.5±0.1 and 
0.4±0.05 after one-week low-fibre periods (LF I and LF II) in Study V. The 
distribution of AR homologues C17:0-C25:0 in plasma and erythrocyte 
membranes after the intake of wheat and rye breads in Study V (n=15) and after 
mixed whole-grain diet in Study III (n=4+4) are shown in Table 8. 
 
 
 
 
 
 
Erythrocyte AR 
(nmol/l packed cells) 
 
Whole-grain 
wheat bread 
diet 
Whole-grain 
rye bread 
diet 
Mixed  
whole-grain 
bread diet 
Low-fibre 
bread diet 
Habitual diet 
Study III 
(n=4+4) - - 
248±65.7a 
(136-436) 
17.2±2.6b 
(13.2-24.3) 
62.5±25.8c/ 
69.6±17.7c 
(16.7-136)/ 
(25.8-107) 
Study V 
(n=15) 
210±17.3a 
(103-324) 
315±31.2a 
(164-627) - 
50.9±6.4c/ 
62.1±4.6c 
(23.0-111)/ 
(24.0-86.3) 
- 
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Table 8. Alkylresorcinol homologue percentages in plasma and erythrocytes after 
one-week intake of mixed whole-grain diet (Study III, n=4+4) and whole-grain wheat and 
rye breads (Study V, n=15) and plasma to erythrocyte alkylresorcinol homologue ratios. 
Erythrocyte values marked (*) differ compared to plasma homologue ratio (paired 
samples test, p < 0.05). 
 
 
Correlations of erythrocyte AR concentrations to plasma AR concentrations 
with and without correction for plasma cholesterol concentrations are shown in 
Figures 11 and 12 after a one-week intake of whole-grain wheat and rye bread 
diets in human subjects in Study V (n=15). Plasma AR correlation to erythrocyte 
concentrations was higher, though not necessarily strong after adjustment to 
cholesterol. 
 
 
 C17:0 C19:0 C21:0 C23:0 C25:0 
 % 
Study III 
Mixed whole-grain bread diet      
Plasma 13±2.3 34±0.75 34±2.6 14±0.18 5±1.2 
Erythrocytes 5±1.5* 31±1.4* 36±2.5 16±2.2 12±0.79* 
Plasma/erythrocytes 1.3±0.13 0.73±0.15 0.71±0.18 0.55±0.12 0.51±0.12 
Study V 
Whole-grain wheat bread diet      
Plasma 5±0.56 23±0.77 53±1.1 15±0.74 4±0.63 
Erythrocytes 3±0.27* 24±0.79 51±0.96* 16±0.67 7±0.55* 
Plasma/erythrocytes 0.90±0.10 0.51±0.07  0.55±0.07 0.50±0.07 0.34±0.06 
Study V 
Whole-grain rye bread diet 
     
Plasma 17±1.4 24±0.89 30±1.0 17±0.74 12±1.1 
Erythrocytes 10±0.57* 27±0.83* 30±1.1 18±0.58 15±1.2* 
Plasma/erythrocytes 1.2±0.10 0.63±0.05 0.72±0.07 0.70±0.09 0.59± 0.08 
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Figure 11. Correlation of erythrocyte alkylresorcinol (AR) concentration (nmol/l packed cells) to plasma alkylresorcinol concentrations 
(nmol/l) and after adjustment for plasma cholesterol and triacylglycerols (nmol/mmol chol + TG) after one-week intake of whole-grain wheat 
in human subjects. (Study V, n=15). 
 
  
 
 
 
 
 
 
 
 
 
Figure 12. Correlation of erythrocyte alkylresorcinol (AR) concentration (nmol/l packed cells) to plasma alkylresorcinol concentrations 
(nmol/l) and after adjustment for plasma cholesterol and triacylglycerols (nmol/mmol chol + TG) after one-week intake of whole-grain rye in 
human subjects. (Study V, n=15). 
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In Study III the correlation (r2) of plasma AR to erythrocyte AR 
concentrations was 0.530 (n=4) after one-week intake of whole-grain breads 
following a one-week low-fibre period, and 0.262 (n=4) after constant intake of 
whole-grain products for two weeks. 
 
In human subjects erythrocyte mean corpuscular volume measured with an 
automatic cell counter did not change during the four-week follow-up (measured in 
one-week periods) in Study V, and AR incorporation into erythrocytes did not 
seem to change the cell size or affect haemoglobin values of the subjects. 
 
4.5 Alkylresorcinol occurrence in lipoproteins (Study V) 
 
We separated human fasting plasma VLDL, LDL, and total HDL with 
ultracentrifugation and analysed AR in these fractions. The samples were taken 
after one-week whole-grain rye and whole-grain wheat bread diets and after low-
fibre diets. There were no differences in plasma or lipoprotein AR concentrations 
between women (n=8) and men (n=7), and therefore the data was combined for 
the analyses (n=15). The results did not differ depending on which whole-grain 
period was first, and the data from the two rye bread periods and that from the two 
wheat bread periods was combined. Lipoprotein concentrations did not change 
during the study.  
 
 AR plasma concentrations (nmol/l) correlated well to plasma AR 
concentrations adjusted for cholesterol and triacylglycerols (TG) (nmol/mmol 
cholesterol + TG) (r2=0.868-0.936 after the different diets, p < 0.001) (Figure 13). 
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Figure 13. Mean plasma alkylresorcinol (AR) concentrations before (nmol/l) and after 
adjustment for plasma cholesterol and triacylglycerols (TG) (nmol/mmol cholesterol + TG) 
with SEM in human subjects (Study V, n=15). 
 
After RD and WD 72±3.9% and 69±2.5% of plasma, AR concentrations 
were measured in the lipoproteins, respectively. The correlation between plasma 
(nmol/l) and total lipoprotein (nmol/l of plasma) AR was strong (r2=0.839, p < 0.05 
(RD), r2=0.939, p < 0.05 (WD)). AR were quantified in all lipoprotein particles, 
proportionally in highest amounts in VLDL. Table 9 shows AR concentrations in 
total cholesterol and in lipoprotein subclasses calculated per litre of plasma.  
 
Table 9. Alkylresorcinol (AR) concentrations in total cholesterol and in lipoprotein 
classes (VLDL, LDL, and HDL) after low-fibre diets and whole-grain wheat and whole-
grain rye bread diets. Values are presented as mean±SEM (range). Means in a column 
without a common letter differ (p < 0.05, Wilcoxon signed rank test). 
 
AR 
(nmol/l plasma) 
 
Low-fibre wheat 
bread diet I 
Whole-grain 
wheat bread diet 
Low-fibre wheat 
bread diet II 
Whole-grain 
rye bread diet 
Tot 
cholesterol 
23.1±7.3 
(6.1-119) 
73.4±10.3a 
(25.7-176) 
20.0±2.4 
(8.6-46.2) 
166±19.7b 
(55.8-329) 
VLDL 
11.7±6.3 
(0-97.5) 
35.8±8.6a 
(3.1-124) 
8.7±2.0 
(1.0-29.9) 
69.4±14.9b 
(4.8-232) 
LDL 
3.9±0.54 
(1.8-8.6) 
16.0±2.1a 
(5.4-35.7) 
4.1±0.59 
(1.3-9.0) 
37.2±4.2b 
(14.9-66) 
HDL 
7.5±1.1 
(3.2-17.7) 
21.7±3.0a 
(6.5-48.6) 
7.2±0.68 
(2.4-13.1) 
59.7±10.6b 
(23.0-172) 
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AR homologue patterns in plasma, erythrocytes, VLDL, LDL, and HDL 
differed after the one-week intake of whole-grain wheat or rye in Study V. The 
homologue patterns also differed when measured from different matrices, 
although some homologues, especially C19:0, C21:0, and C23:0, existed in more 
similar proportions in the measured matrices. Plasma AR homologue pattern was 
closest to that of the breads consumed. Retinol (431-453 mg/l), α-tocopherol (8.2-
8.6 mg/l) and γ-tocopherol (0.67-0.84 mg/l) concentrations did not change 
significantly during the follow-up (Study V). 
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5 Discussion 
 
5.1 Method development and analysis of alkylresorcinols in 
plasma and biological membranes 
 
Ross et al. reviewed the analysis methods for AR in foods and in biological 
samples (Ross et al. 2004c). Rauls and Penney analysed less lipophilic olivetol 
than AR in rabbit serum with HPLC-UV (Rauls and Penney 1982). AR metabolites 
have been analysed in urine by GC-MS after enzymatic hydrolysis and purification 
with thin layer chromatography (TLC), and intact AR in human and pig ileal 
digesta and faeces by GC-MS and GC-FID (Ross et al. 2003a, Ross et al. 2003b, 
Ross et al. 2004d). TLC purification and analysis with TLC and GC has been used 
for measurement of AR in rat adipose tissue and blood cells (Ross et al. 2004a), 
and HPLC-radiochemical detection has been used to detect 14C-labelled AR 
metabolites in rat plasma, urine, and faeces (Ross et al. 2003b).  
 
In the first study of this work a novel method for the analysis of AR in 
plasma samples was developed. AR can be measured from plasma with a 
relatively simple and fast quantitative GC-MS method that consists of extraction of 
alkylresorcinols from plasma, purification of the sample and analysis by GC-MS. 
During method development we noticed that enzymatic hydrolysis with sulphatase 
or β-glucuronidase did not increase measured plasma AR concentrations, 
indicating that AR are transported unconjugated in plasma. However, over-night 
incubation increased the yield compared to 3 h incubation, which is probably due 
to AR binding to plasma proteins, and liberation of them during the incubation. 
Later on we found that AR are incorporated into lipoproteins, which partly explains 
these findings. Diethyl ether was chosen as the extraction solvent due to its best 
extraction properties and easy evaporation. It has a dielectric constant of 4.33, 
which is between that of the tested petroleum ether and ethyl acetate, and it 
seemed to be most appropriate extraction solvent for lipophilic AR.  
 
The GC-MS method presented here is the first quantitative method using 
synthethic reference compounds identical to the analytes and similarly behaving 
internal standard suitable for analysis of AR in biological samples in larger scale. 
We used synthetic internal standard AR C20:0, which does not naturally occur in 
plasma. Deuterium labelled or 13C analogues for all AR homologues used as 
internal standards behaving identically to the analytes during sample pre-
treatment and analysis, would have been the most accurate option and provide 
the best quantisation, but these were not available. AR C20:0 in the GC-MS 
elutes in the middle of all AR homologues, which might cause deviation of the 
results for longer and shorter chain AR eluting further away from C20:0. The same 
happens for the reference compounds used to quantify the analytes, which partly 
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corrects the deviation. AR C23:0 reference compound was used to quantify C25:0 
due to lack of a synthetic AR C25:0. This can cause underestimation of C25:0 
concentrations in the samples. The error, however, should be small according to 
the results we achieved when other AR homologues were calculated in a similar 
manner with AR reference compounds with alkyl chains two carbons shorter. High 
recovery in reference compounds during the method development can be 
explained with endogenous AR, although the blank was reduced from the values. 
The recoveries were measured with reference compounds and their 
concentrations could vary and cause deviation in the results. The same analysis 
method as for plasma was used for quantisation of lipoprotein AR with the 
exception at the extraction with diethyl ether, which was done four times to 
achieve better analyte recovery from fatty samples. The high CV in lipoprotein 
control samples is due to very low concentrations of AR in them, but these 
samples were the only ones available. The advantage of the plasma analysis 
method is fast and selective purification by ion-exchange chromatography instead 
of TLC. GC-MS is selective and highly sensitive and therefore only a fraction of a 
sample is needed. 
 
In erythrocyte AR analysis we first isolated the cell membranes and 
analysed AR in those. We found out that the concentrations were the same as 
measured from washed, whole erythrocytes indicating that AR are incorporated 
into the cell membranes and that we actually measured the AR incorporated into 
the membranes instead of AR externally bound to the cells. We did not analyse 
unwashed cells, however. The analysis method was adapted from erythrocyte 
vitamin E analysis (Bieri et al. 1979, Simon et al. 2001). Vitamin E structure is 
similar to that of AR and is known to be incorporated into erythrocyte membranes. 
In a pilot study with human subjects (Study III) 0.15 M NaCl (0.9%) in 10 mM Na-
phosphate buffer was used as a washing solution, but it was changed to 0.9% 
NaCl-solution that was more easily available (Study V). The two different solutions 
did not change the results. In Study III a 50% haematocrit solution of the washed 
cells was prepared and the haematocrit value, which was used in the 
concentration calculations, was measured. In Study V the washed cells were 
pipetted and the pipetting volume was used in the calculations. The precision with 
the latter method was better although pipetting the thick cell solution caused minor 
variation in the volumes.  
 
5.2 Absorption and distribution of alkylresorcinols in plasma 
 
AR absorption was tested in a pig model with habitual intake of AR and 
with a single feeding with AR-rich bread. There were no differences in the 
mesenteric artery and the portal vein AR concentrations during the absorption. 
This indicates that AR are not absorbed into the bloodstream via portal vein from 
the gut like amino acids, sugars, and short-chain fatty acids, but are absorbed via 
the lymphatic system like other lipophilic compounds. Since there were no 
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differences in arterial and venous AR concentrations, we were not able to 
calculate the actual absorption over time or dose-dependent absorption, but a 
response in plasma AR concentrations to AR intake was seen. With a single 
feeding a higher and sharper peak with more equal within and between pig 
concentrations of plasma AR was seen compared to prolonged AR consumption. 
This can be due to 24 h fasting before the feeding of the bolus of AR-rich whole-
grain rye bread, and therefore accelerated gastric emptying and more effective 
absorption.  
 
Time of the peak AR concentration (3-4 h) after single rye bread intake in 
pigs was similar to that of tocotrienols (3.3-4.4h for tocotrienols, as was the 
apparent elimination half-life, 3.93 h for AR (2.3-4.4 h for tocotrienols) 
(Schwedhelm et al. 2003, Yap et al. 2004). With human subjects a longer 
apparent elimination half-life, 4.8 h, was found (Landberg et al. 2006). This 
difference in the results remains to be clarified. Longer tmax-values (~10 h) for 
radiolabelled AR in a previous study with rats might indicate that in those studies 
AR metabolites, rather than intact, absorbed AR were measured (Ross et al. 
2003b). The difference can also be due to heterogeneity in dietary habits or 
species specific factors. 
 
In our study with pigs all AR homologues were absorbed in a similar 
manner. Plasma AR homologue pattern reflected that of the diet. This is in 
contrast to later studies with AR absorption in human subjects, where relative 
proportions of AR C23:0 and C25:0 increased in plasma, and C17:0 decreased 
over 1-5 hour period after a single intake of 190 mg of AR in rye bread (Landberg 
et al. 2006). In some pigs two peaks at 3-4 h and 6-9 h in AR plasma 
concentrations were seen, which could be caused by enterohepatic circulation or 
colonic absorption. This data is similar to that obtained with human subjects after 
single intake of AR, when two peaks in the absorption curves were seen, first at 2-
3.2 hours, and the second at 6.6-6.8 hours (Landberg et al. 2006). Low within and 
between animal variations in AR concentrations with single rye feeding together 
with high inter-animal variation during habitual rye feeding might be due to 
individual metabolism and storage of AR in body tissues and liberation of them 
during constant intake. We detected AR in pig plasma (~30 nmol/l) after five to 
seven days controlled AR-free diet for, and after feeding the pigs with this diet, AR 
concentrations rose up to 74 nmol/l peaking at 3 h. This can be due to storage of 
AR in cell membranes or fatty tissues, and their liberation into bloodstream even 
with no AR intake. The slight peaking in AR concentrations could also indicate 
enterohepatic circulation. It is also possible that the pigs ate some AR in the diet, 
e.g. in the breads, although AR were not detected in the samples of the bread fed 
to the pigs during the AR-free diet period. This data is in contrast to studies with 
rats fed with radioactive AR (Ross et al. 2003b), where no radioactivity in blood 
was detected after 60 h. This might be caused by AR metabolism or differences in 
measurement techniques, lack of sensitivity of liquid scintillation counting, or other 
measurement dependent factors, or species-specific differences. 
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We showed that AR are incorporated into human erythrocyte membranes 
during the intake of whole-grain products. The ratio of AR in plasma and 
erythrocytes was 0.7±0.1 after whole-grain rye diet and 0.5±0.1 after whole-grain 
wheat diet (Study V, n=15). This ratio is similar, especially after high intake of AR 
from whole-grain rye bread, to that found for α- (0.80) and γ-tocopherol (0.67) 
when erythrocyte tocopherols were related to plasma lipids (Lehmann et al. 1988), 
and when 2H-labelled α-tocopherol enrichment was tested in erythrocytes (45% 
enrichment) (Jeanes et al. 2005), suggesting that the distribution of AR in plasma 
and blood cells is similar to that of tocopherols. This is logical, since the AR 
molecular structure and thereafter e.g. the properties in distribution are similar to 
those for tocopherols. Based on our studies, there is no evidence of a specific 
transporter as for tocopherols (Hosomi et al. 1997). It is possible, however, that 
AR use, if any, the same transporters as tocopherols. 
 
In Study III with human subjects it appeared that longer-chain AR are 
incorporated into erythrocytes in a higher proportion than shorter-chain AR. This is 
in agreement with in vitro studies (Kozubek and Tyman 1999), and is likely to be 
caused by higher hydrophobicity of long-chain AR and therefore more prone 
incorporation into lipophilic environment. In Study V with human subjects a similar 
tendency, but to lower extent, was seen with longer-chain AR. In Study V, the AR 
concentrations in erythrocytes during one-week low-fibre diet remained higher 
compared to Study III. This could be caused by more intensive whole-grain 
consumption and accumulation of AR in tissues and into the cell membranes 
during the whole-grain bread weeks in Study V, although the concentrations after 
the whole-grain periods were similar in both studies. In vitro studies have shown 
membrane permeability changes when AR are incorporated into them (Kozubek 
and Tyman 1999 and references therein). AR incorporation into erythrocytes did 
not change their size, measured with an automatic cell counter (Study V), 
indicating that no swelling or shrinkage due to permeability changes occurred in 
vivo. AR concentrations used in vitro have been 3.5-30 µmol/l (Kozubek 1987a, 
Kozubek 1987b). In our studies, the highest measured concentrations from fasting 
samples were 627 nmol/l packed cells. It is possible that soon after absorption 
higher AR concentrations in erythrocytes exist, which could have an effect on 
permeability properties. It is unlikely, however, that concentrations would reach 
the concentrations used in vitro. 
 
In Study V, AR occurrence in lipoproteins VLDL, LDL, and HDL isolated 
from human plasma samples was examined. It was shown that AR are 
incorporated into all lipoprotein classes and seem to be transported exclusively in 
lipoproteins in human plasma in an unconjugated form. The amount of AR 
measured from all the lipoprotein fractions was close to that of total plasma AR 
related to plasma cholesterol level. Adjusting AR plasma concentrations to 
cholesterol gave better correlation to erythrocyte concentrations. Since AR are 
mainly transported in plasma lipoproteins (69-72%), it could be reasonable to 
adjust plasma AR concentrations to cholesterol concentrations as is 
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recommended for vitamin E to eliminate variations in carrier lipoprotein 
concentrations (Behrens et al. 1982, Bjørneboe et al. 1990). 
 
In Study V, the AR homologue composition differed after whole-grain wheat 
and rye bread diets, and somewhat also in the measured matrices, plasma, 
erythrocytes, and lipoproteins, probably due to differences in incorporation of the 
homologues into the membranes. AR homologue patterns in plasma, 
erythrocytes, or lipoproteins did not correlate to each other when determined from 
different matrices. Plasma AR homologue pattern seemed to best reflect that of 
the bread consumed. VLDL had the greatest capacity to carry AR. However, since 
VLDL is present in small amounts in plasma, HDL together with VLDL seem to be 
the main AR carriers when AR concentrations are related to lipoprotein plasma 
concentrations (e.g. VLDL nmol/l plasma). LDL had AR concentrations about half 
of that in VLDL and HDL. This is in contrast to α-tocopherol, for which LDL and 
HDL are the main carriers in human fasting plasma. As for AR, VLDL had the 
greatest capacity to carry α-tocopherol, but contained proportionally lowest 
amounts of α-tocopherol (Behrens et al. 1982, Bjørnson et al. 1976). In nonfasting 
rats α-tocopherol was distributed between VLDL and HDL (Bjørneboe et al. 1986, 
Bjørneboe et al. 1990). In men LDL carried more α-tocopherol than HDL (Behrens 
et al. 1982), but this was not observed for AR in our study. 
 
AR seem to be absorbed via the lymphatic system from the small intestine 
in chylomicrons, are most probably transported to liver, and from there to VLDL. 
From VLDL they can be redistributed to HDL and to LDL. HDL can possibly 
receive AR straight from chylomicrons, which would explain higher AR 
concentrations in HDL compared to LDL. This absorption pathway is comparable 
to that of lipophilic tocopherols, with chemical structure resembling that of AR 
(Bjørneboe et al. 1990, Frank 2005). Peripheral tissues, especially adipose and 
other fatty tissues, could also receive AR via lipoproteins. In rats, for example, AR 
are found in the adipose tissues (Ross et al. 2004a). Hypothetically, from LDL, AR 
could be delivered into macrophages or atherosclerotic plaques where they could 
have stabilizing effects, since in vitro AR can stabilize e.g. phospholipid bilayers 
(Gubernator et al. 1999, Kozubek et al. 1988, Kozubek and Tyman 1999). These 
theories naturally demand further research. The absorption, distribution, 
suggested metabolism and excretion of AR (Ross et al. 2004b, Ross et al. 2004d) 
are presented in Figure 14. 
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Figure 14. Suggested absorption, metabolism, and excretion of alkylresorcinols 
*(Ross et al. 2004b, Ross et al. 2004d). 
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Kamal-Eldin et al. (2001) found no changes in antioxidant activities with AR 
in vitro, but admitted that more studies of membrane stabilising and possible 
antioxidative effects of AR in the membranes, together with in vivo studies, should 
be performed to be able to conclude whether AR can function as antioxidants 
(Kamal-Eldin et al. 2001). Parikka et al. (2005) showed reduced LDL oxidation 
susceptibility with in vitro concentrations of 25 µmol/l with C15:0. Compared to our 
studies, the concentrations were high. It is unlikely that these concentrations could 
be reached in vivo. In our studies maximum concentrations were 766 nmol/l in 
plasma and 176 nmol/l of plasma in lipoproteins.  
 
It is possible that AR cause changes in LDL and HDL membranes and 
therefore affect the oxidation susceptibility in this manner. AR antioxidant activity 
has been explained also to be due to their indirect effects on tocopherol, 
especially γ-tocopherol, levels (Kamal-Eldin et al. 2001, Ross et al. 2004a). Intake 
of AR increased γ-tocopherol concentrations in the liver in rats, and in vitro -
studies have shown inhibitory effects of AR on γ-tocopherol metabolism (Ross et 
al. 2004a). In our study, α- and γ- tocopherol, as well a retinol, concentrations 
remained stable during the one-week intake of whole-grain wheat and rye bread. 
AR did not seem to affect the measured serum antioxidant concentrations. 
Cholesterol concentrations also remained unchanged during the one-week 
interventions. In our studies no liver or other tissue tocopherol or cholesterol 
concentrations were determined. It is possible that AR can cause changes in 
these tissues in the human body and affect the cell membrane properties, and 
directly or indirectly affect oxidative susceptibility. 
 
Jenkins et al. (2002) saw no change in LDL oxidation susceptibility after 
intake of wheat bran for three months. The amount of formed conjugated dienes 
was measured, but no LDL oxidation resistance (lag-time) that commonly is used 
to measure LDL oxidation susceptibility was presented (Jenkins et al. 2002). 
Therefore the results are not directly comparable to our study. In the study by 
Harder et al. (2004) with intake of rye bran enriched bread for six weeks, no 
reduction of LDL oxidation lag time compared to habitual diet or wheat diet was 
reported. Habitual diet was used as a wash-out period, but bread intake was not 
restricted and the dietary intervention may not have been sufficient enough to 
affect LDL oxidation susceptibility, and the in vitro analysis of oxidation might not 
measure the changes caused by hydrophilic ferulic acid, which was tested as the 
active compound. (Harder et al. 2004). Jones et al. (2004) investigated plasma 
antioxidant capacity and urine antioxidant output after consumption of three daily 
portions (23 g) of whole-grain food for eight weeks, continued with six daily 
servings (23 g) of whole-grain food for another eight weeks. They reported 
progressively increasing antioxidant output in urine with increased whole-grain 
intake, but plasma antioxidant capacity did not change. There was speculation 
that fasting plasma samples were not good indicators of the antioxidant status 
(Jones et al. 2004, Seal 2006). Our study showed that AR are incorporated into 
human plasma lipoprotein particles. This differs from several other antioxidative 
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compounds that often are hydrophilic and stay in extracellular compartments, 
which can affect their efficacy on lipoprotein oxidation susceptibility. 
 
5.3 Alkylresorcinols as biomarkers of whole-grain intake 
 
AR concentrations increased significantly in all experiments after the intake 
of whole-grain products and decreased during low-fibre diets. With gluten-free and 
thereafter cereal-free diets no AR could be detected in human plasma. However, 
after low-fibre diets following habitual or increased consumption of whole-grain 
products, low amounts of AR could be detected in human or pig plasma. This 
suggests that AR are stored in tissues or cell membranes, or in lipoproteins and 
can be slowly liberated from there into plasma. 
 
AR are absorbed rapidly form the small intestine, and their elimination half-
life is rather short (3.93 h), according to our studies. With a single feeding of AR-
rich whole-grain rye bread, pig plasma AR concentrations decreased within 16 
hours, but remained nearly five times higher compared to the baseline. With 
constant intake of whole-grain rye in the same pigs, the AR concentrations were 
high after over-night fasting. A similar effect was seen in all human studies when 
constant intake of whole-grain rye or wheat was compared to low-fibre diets. With 
habitual Finnish diets AR concentrations were higher than with one- to eight-week 
low-fibre diets in all studies. Plasma AR concentrations appeared to further 
increase with all subjects with increased intake of whole-grain wheat or rye 
products. In Study II, a correlation between AR plasma concentrations and intake 
of rye bread was seen. However, in Study V with one-week constant intake of 
whole-grain rye or wheat, no correlation on individual basis between bread, AR, or 
fibre intake to fasting plasma or erythrocyte AR concentrations was seen. We did 
not find a dose-dependent relationship with the intake of cereal products and 
plasma or erythrocyte AR. When mean values of plasma AR concentrations from 
all subjects were evaluated, a clear and statistically significant increase in plasma 
AR concentrations compared to increasing AR intake from whole-grain wheat and 
rye breads was seen. 
 
 In Study V after the intake of the same amount of AR (mg/d) in the diet, a 
large inter-individual variation in plasma after whole-grain wheat bread diet (34.4-
231 nmol/l) and whole-grain rye bread diet (55.1-389 nmol/l) was seen. This can 
be explained by differences in individual factors affecting AR absorption, such as 
nutritional status, other foods consumed together with the test bread, including the 
amount of fat in the diet, and factors affecting the transit time and function of the 
intestinal tract. In Study V, a large variation in erythrocyte AR concentrations 
especially after one-week low-fibre periods compared to Study III was found. After 
Study III, it was speculated whether erythrocyte AR could be used as long-term 
biomarkers due to more stable concentrations after low-fibre diet. Erythrocyte AR 
concentrations were higher compared to plasma indicating AR storage in the 
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membranes, which potentially could reflect long term intake. Plasma and 
erythrocyte AR concentrations correlated, though not necessarily strongly 
(r2=0.484 with rye diet in Study V (n=15) and r2=0.530 with mixed whole-grain diet 
in Study III (n=4)). The correlation was stronger after adjustment of plasma AR 
concentrations to plasma cholesterol and triacylglycerols (r2=0.8151 in Study V 
(n=15)). Erythrocyte AR concentrations did not correlate to the intake of AR or 
breads from the diet. The potential usability of erythrocyte AR as long-term 
biomarkers should be investigated in studies with prolonged whole-grain intake 
and following low-fibre bread diet when AR plasma and erythrocyte 
concentrations are monitored. 
 
Average serum ENL concentrations increased significantly during yhe 
eight-week intake of whole-grain rye in Study II in women (p < 0.05, n=39) and the 
one-week intake of whole-grain rye in Study V in men (p < 0.05, n=7), but not in 
women in Study V (n=8). When whole-grain products were removed from the diet 
for one week, ENL concentrations in men dropped to half, while only a slight 
decrease in concentrations was seen in women. Again, in men, a significant 
increase in ENL concentrations with one-week intake of whole-grain rye was 
seen. Serum ENL concentrations in men were lower compared to women, but the 
difference between women and men reached statistical significance (p < 0.05) 
only during the low-fibre diets. This data indicates that women receive plant 
lignans and then produce ENL from other sources than whole-grain products in 
higher amounts than men, or that intestinal microflora is remarkably different in 
women compared to men in this study. There were individuals in Study II and V 
whose ENL concentrations did not increase at all with intake of rye bread, while 
AR concentrations did increase and no intake of antibiotics was recorded. Since 
plasma AR concentrations with the same individuals increased, these individuals 
did consume whole-grain products. In certain cases, ENL concentrations even 
decreased with the intake of rye. Similar cases with minimal changes in ENL 
concentrations with intake of plant lignans have been seen in previous studies 
(Stumpf et al. 2000a). This could be caused by inactive intestinal microflora or 
other individual metabolic events that result in inefficient conversion of plant 
lignans to ENL. In Study II, serum ENL concentrations were higher after the eight-
week habitual diet, low-fibre wheat bread diet, and whole-grain rye intake 
compared to Study V with one-week dietary interventions, indicating higher intake 
of plant lignans by individuals in Study II. In Study II, the subjects were older 
(59±0.94 years with BMI 26.8±0.5 kg/m2) postmenopausal women, while in Study 
V women (n=8) were 27±2.1 years old with BMI 23.3±1.0 and men (n=7) were 
22±0.37 years old with BMI 25.7±1.7. The subjects in Study II were recruited from 
Eastern Finland and in Study V from the Helsinki area. These differences in the 
subjects’ ages and the place of residence may affect dietary habits and probably 
explain the differences in ENL concentrations.  
 
These results show that ENL is not a specific biomarker of whole-grain 
intake. In contrast to ENL, plasma AR concentrations rose, although to different 
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extents, in all subjects after the intake of whole-grain products. The response of 
AR concentrations to the intake of whole-grain products was more constant and 
predictable compared to ENL. AR are absorbed as such from the digestive tract. 
This data shows that plasma AR compared to serum ENL could better function as 
specific biomarkers for whole-grain intake, although this study did not directly 
evaluate the usability of ENL as a dietary biomarker. ENL has been thought to 
reflect the intake of lignans in the diet, and generally healthy dietary habits, and 
enterolactone to enterodiol –ratio could potentially be used as a marker of the 
function of the intestinal microflora (Kilkkinen et al. 2001, Kilkkinen et al. 2002, 
Stumpf 2004). In addition, enterodiol measured together with ENL is thought to be 
a better marker of lignan intake than ENL alone, although even then the intra-
individual variation remained high (Peñalvo et al. 2005b). 
 
Some authors have presented hypotheses that cereal-based diet could be 
a cause for chronic diseases (Jönsson et al. 2005), although even then the main 
cause has been reasoned to be highly refined cereal products (Cordain et al. 
2005). Measuring serum ENL and plasma AR together could provide information 
on dietary habits, and possibly distinguish a difference between the intake of fibre-
rich whole-grain cereals from other fibre-rich products abundant in plant lignans, 
such as seeds, vegetables, and fruits. This could elucidate the possible protective 
role of whole-grain cereals for chronic diseases compared to other sources of 
dietary fibre in the human diet. A trial with controlled intake of whole-grain bread 
and careful recording of fruit and vegetable intake should be conducted to confirm 
these ideas and to compare responses in plasma AR and serum ENL 
concentrations to dietary factors. 
 
Total plasma AR concentrations together with AR C17:0/C21:0 –ratio may 
determine the intake of whole-grain wheat and rye products. Plasma AR 
concentrations after habitual diet seemed to increase even after single intake of 
high amount of rye bread. However, C17:0/C21:0 –ratio increased only after a 
regular intake of rye products. Low C17:0/C21:0 –ratio together with low total 
plasma AR concentration showed that the subject had consumed mainly low-fibre 
wheat products. In certain individuals, relatively low plasma AR values did occur 
during habitual diets after recorded intake of rye or other whole-grain cereals (~50 
nmol/l), but even then the C17:0/C21:0 -ratio was high (~0.5 or more). The 
C17:0/C21:0 -ratio was 0.60-0.84 after controlled whole-grain rye bread intake 
and 0.10-0.12 after controlled whole-grain wheat bread intake. After habitual diet 
the mean C17:0/C21:0 -ratio was lower (0.28±0.05 and 0.52±0.09 (a one-week 
period)) in Study V with 15 subjects compared to Study II with 39 subjects 
(0.74±0.06 and 0.68± 0.05 (an eight-week period)). After controlled low-fibre 
intake with 39 women in Study II (an eight-week period) and in four pigs in Study 
IV (5-7 days), the ratio was relatively high (0.53 and 0.47), compared to Study V, 
in which the ratio was 0.01-0.05. Subjects in Study II were allowed to eat 
additional cereal products, and were followed for longer period than in Study V, 
which can affect dietary compliance. Also species-specific differences can explain 
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the different results between human subjects and the pigs. In all studies a 
constant intake of rye bread significantly increased the AR C17:0/C21:0 -ratio. On 
average, plasma AR concentrations about 35 nmol/l seem to reflect low-fibre 
based diet, and concentrations above 200 nmol/l indicate a high intake of whole-
grain rye-based products in the diet. We suggest that AR C17:0/C21:0 -ratio 
together with the total AR concentration in plasma could be used as an indicator 
of the intake of whole-grain cereals and more specifically the type of cereals, i.e. 
the higher the ratio, the more whole-grain and especially rye based products have 
been included in the diet. This data supports the usability of total plasma AR 
concentration together with the homologue C17:0/C21:0 –ratio as specific 
biomarkers of the intake of whole-grain products in the diet. 
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6 Conclusions 
 
The present work aimed to determine the usability of cereal alkylresorcinols 
(AR) as biomarkers of the intake of whole-grain products in the human diet. The 
aim was to analyse AR in human plasma, determine their absorption and 
responses in plasma concentrations after the intake of whole-grain wheat or rye 
products, and to analyse their occurrence in certain biological membranes. A pig 
model was used to determine AR absorption and elimination kinetics. The results 
of the study can be summarised as follows: 
 
I AR can be determined and quantified with the use of analogous reference 
compounds in human plasma, erythrocyte membranes, and lipoproteins by GC-
MS. 
II AR are absorbed via lymphatic system from the small intestine, and are 
transported in plasma mainly in lipoproteins, VLDL and HDL being the main 
carriers. The absorption and transportation of AR resembles that of the 
structurally similar tocopherols. Relating plasma AR concentrations to cholesterol 
and triacylglycerols in plasma might provide more accurate estimation of the 
individual AR status by eliminating the effects in variation of carrier lipoprotein 
concentrations. Some results suggest that enterohepatic circulation is possible, 
but the exact mechanism and the nature of the possible compounds in bile are 
uncertain. 
III Plasma AR concentrations increase systematically, although not 
necessarily dose-dependently on individual basis, after the intake of whole-grain 
wheat or rye products. Mean plasma AR concentrations (nmol/l) significantly 
increased with increasing intake of AR from the diet (mg/d). The increase in 
plasma AR concentrations after whole-grain intake is more regular and 
predictable than that of enterolactone (ENL). Plasma AR concentrations gave 
better estimation of the intake of whole-grain products in the diet compared to 
ENL.  
IV AR C17:0/C21:0 -ratio was higher after whole-grain wheat and rye 
intake compared to low-fibre diets. The total AR concentration in plasma together 
with homologue C17:0/C21:0 -ratio could be used as specific dietary biomarkers 
to determine the amount and the type of whole-grain products in the diet providing 
a valuable tool in epidemiological studies when the role of the diet for human 
health is evaluated. Plasma AR and serum ENL together could be used as dietary 
biomarkers to show the origin of the main source of dietary fibre, whether it is 
mainly from whole-grain cereals or other plant origin foods. 
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7 Future studies 
 
The usability of AR as biomarkers should be confirmed in a larger and 
prolonged study with controlled and variable intake of whole-grains. AR 
concentrations in plasma and erythrocytes should be followed with habitual diet, 
continuous intake of whole-grain products, and recorded intake (e.g. food diaries) 
of whole-grain cereals. Follow-up should be continued after a change to low-fibre 
diet to follow the decrease of AR concentrations in plasma and erythrocytes 
membranes. For this, at best, a faster analysis method suitable for analysis of 
multiple samples should be developed. Such a method could be a high 
performance liquid chromatography method that requires less sample pre-
treatment than GC-MS or time-resolved fluoroimmunoassay suitable for the 
analysis of several samples at the same time with relative ease. Possible AR 
metabolites in urine should be determined after intake of whole-grain cereals to 
better understand AR metabolism in humans. Also, LDL oxidation and possible 
effects of AR on the oxidation susceptibility after prolonged intake of whole-grains 
should be followed. 
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